SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Xerox Holdings Corp., et al. – ‘10-Q’ for 3/31/21

On:  Friday, 4/30/21, at 4:36pm ET   ·   For:  3/31/21   ·   Accession #:  1770450-21-25   ·   File #s:  1-04471, 1-39013

Previous ‘10-Q’:  ‘10-Q’ on 11/4/20 for 9/30/20   ·   Next:  ‘10-Q’ on 8/4/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 10/30/23 for 9/30/23   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/30/21  Xerox Holdings Corp.              10-Q        3/31/21  111:15M
          Xerox Corp.

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.59M 
 2: EX-4.1      EX-4.1 Registration Rights Agreement                HTML    155K 
 4: EX-10.10    EX-10.10 Dsu Award Summary - Xhc for Ned            HTML     30K 
 5: EX-10.11    EX-10.11 Rsu Award Agreement - Xhc for Ned          HTML     39K 
 6: EX-10.12    EX-10.12 Rsu Award Summary - Xhc for Ned            HTML     30K 
 3: EX-10.9     EX-10.9 Dsu Award Agreement - Xhc for Ned           HTML     40K 
 7: EX-31.A(1)  EX-31.A(1) Xerox Holdings Corporation CEO           HTML     33K 
                Certification                                                    
 8: EX-31.A(2)  EX-31.A(2) Xerox Corporation CEO Certification      HTML     33K 
 9: EX-31.B(1)  EX-31.B(1) Xerox Holdings Corporation CFO           HTML     33K 
                Certification                                                    
10: EX-31.B(2)  EX-31.B(2) Xerox Corporation CFO Certification      HTML     33K 
11: EX-32.A     EX-32.A Xerox Holdings Corporation Sox              HTML     32K 
                Certification                                                    
12: EX-32.B     EX-32.B Xerox Corporation Sox Certification         HTML     31K 
19: R1          Cover Page                                          HTML     87K 
20: R2          Condensed Consolidated Statements of Income (Loss)  HTML    118K 
                (Unaudited)                                                      
21: R3          Condensed Consolidated Statements of Comprehensive  HTML     70K 
                Income (Loss) (Unaudited)                                        
22: R4          Condensed Consolidated Balance Sheets (Unaudited)   HTML    161K 
23: R5          Condensed Consolidated Balance Sheets               HTML     37K 
                (Parenthetical) (Unaudited)                                      
24: R6          Condensed Consolidated Statements of Cash Flows     HTML    134K 
                (Unaudited)                                                      
25: R7          Basis of Presentation                               HTML     37K 
26: R8          Recent Accounting Pronouncements                    HTML     45K 
27: R9          Revenue                                             HTML     73K 
28: R10         Lessor                                              HTML     59K 
29: R11         Supplementary Financial Information                 HTML     68K 
30: R12         Accounts Receivable, Net                            HTML    373K 
31: R13         Finance Receivables, Net                            HTML    373K 
32: R14         Inventories and Equipment on Operating Leases, Net  HTML     43K 
33: R15         Lessee                                              HTML     51K 
34: R16         Restructuring Programs                              HTML     70K 
35: R17         Debt                                                HTML     56K 
36: R18         Financial Instruments                               HTML     71K 
37: R19         Fair Value of Financial Assets and Liabilities      HTML     66K 
38: R20         Employee Benefit Plans                              HTML    108K 
39: R21         Shareholders' Equity of Xerox Holdings              HTML    115K 
40: R22         Shareholders' Equity of Xerox                       HTML    173K 
41: R23         Other Comprehensive Income (Loss)                   HTML     74K 
42: R24         Earnings??(Loss) per Share                          HTML     67K 
43: R25         Contingencies and Litigation                        HTML     70K 
44: R26         Subsequent Event                                    HTML     33K 
45: R27         Recent Accounting Pronouncements (Policies)         HTML     40K 
46: R28         Revenue (Tables)                                    HTML     69K 
47: R29         Lessor (Tables)                                     HTML     71K 
48: R30         Supplementary Financial Information (Tables)        HTML     70K 
49: R31         Accounts Receivable, Net (Tables)                   HTML     60K 
50: R32         Finance Receivables, Net (Tables)                   HTML    339K 
51: R33         Inventories and Equipment on Operating Leases, Net  HTML     46K 
                (Tables)                                                         
52: R34         Lessee (Tables)                                     HTML     51K 
53: R35         Restructuring Programs (Tables)                     HTML     74K 
54: R36         Debt (Tables)                                       HTML     54K 
55: R37         Financial Instruments (Tables)                      HTML     70K 
56: R38         Fair Value of Financial Assets and Liabilities      HTML     67K 
                (Tables)                                                         
57: R39         Employee Benefit Plans (Tables)                     HTML    106K 
58: R40         Shareholders' Equity of Xerox Holdings (Tables)     HTML    117K 
59: R41         Shareholders' Equity of Xerox (Tables)              HTML    165K 
60: R42         Other Comprehensive Income (Loss) (Tables)          HTML     75K 
61: R43         Earnings??(Loss) per Share (Tables)                 HTML     67K 
62: R44         Contingencies and Litigation (Tables)               HTML     39K 
63: R45         Basis of Presentation (Details)                     HTML     33K 
64: R46         Revenue - Disaggregation of Revenue (Details)       HTML     63K 
65: R47         Revenue - Narrative (Details)                       HTML     43K 
66: R48         Revenue - Incremental Direct Costs (Details)        HTML     32K 
67: R49         Lessor (Details)                                    HTML     42K 
68: R50         Supplementary Financial Information - Cash, Cash    HTML     44K 
                Equivalents and Restricted Cash (Details)                        
69: R51         Supplementary Financial Information - Restricted    HTML     35K 
                Cash Balance Sheet Location (Details)                            
70: R52         Supplementary Financial Information - Supplemental  HTML     61K 
                Cash Flow Information (Details)                                  
71: R53         Accounts Receivable, Net - Summary (Details)        HTML     60K 
72: R54         Accounts Receivable, Net - Accounts Receivable      HTML     34K 
                Sales Arrangements (Details)                                     
73: R55         Finance Receivables, Net - Summary (Details)        HTML     62K 
74: R56         Finance Receivables, Net - Allowance for Credit     HTML     72K 
                Losses (Details)                                                 
75: R57         Finance Receivables, Net - Credit Quality           HTML    111K 
                Indicators (Details)                                             
76: R58         Finance Receivables, Net - Aging of Billed Finance  HTML     91K 
                Receivables (Details)                                            
77: R59         Finance Receivables, Net - Secured Borrowings and   HTML     41K 
                Collateral (Details)                                             
78: R60         Inventories and Equipment on Operating Leases, Net  HTML     38K 
                - Summary of Inventories (Details)                               
79: R61         Inventories and Equipment on Operating Leases, Net  HTML     37K 
                - Equipment on Operating Leases and Accumulated                  
                Depreciation (Details)                                           
80: R62         Inventories and Equipment on Operating Leases, Net  HTML     31K 
                - Additional Information (Details)                               
81: R63         Lessee - Additional Information (Details)           HTML     42K 
82: R64         Lessee - Components of Lease Expense (Details)      HTML     39K 
83: R65         Lessee - Operating Lease ROU Asset, Net and         HTML     43K 
                Operating Lease Liabilities (Details)                            
84: R66         Restructuring Programs - Additional Information     HTML     54K 
                (Details)                                                        
85: R67         Restructuring Programs - Information Related to     HTML     56K 
                Restructuring Program Activity (Details)                         
86: R68         Restructuring Programs - Summary Of Reconciliation  HTML     36K 
                to Statements of Cash Flows (Details)                            
87: R69         Restructuring Programs - Certain Related Costs      HTML     37K 
                Incurred in Connection with Restructuring Programs               
                (Details)                                                        
88: R70         Debt - Narrative (Details)                          HTML     77K 
89: R71         Debt - Special Purpose Entity (Details)             HTML     63K 
90: R72         Debt - Interest Expense and Income (Details)        HTML     37K 
91: R73         Financial Instruments - Additional Information      HTML     58K 
                (Details)                                                        
92: R74         Financial Instruments - Summary of Derivative       HTML     52K 
                Instruments Fair Value (Details)                                 
93: R75         Financial Instruments - Summary of Derivative       HTML     48K 
                Instruments Gain (Losses) (Details)                              
94: R76         Financial Instruments - Summary of Gains (Losses)   HTML     35K 
                Non-designated Derivative Instruments (Details)                  
95: R77         Fair Value of Financial Assets and Liabilities -    HTML     49K 
                Recurring (Details)                                              
96: R78         Fair Value of Financial Assets and Liabilities -    HTML     53K 
                Nonrecurring (Details)                                           
97: R79         Employee Benefit Plans (Details)                    HTML    118K 
98: R80         Shareholders' Equity of Xerox Holdings -            HTML     85K 
                Shareholders' Equity (Details)                                   
99: R81         Shareholders' Equity of Xerox Holdings - Treasury   HTML     48K 
                Stock (Details)                                                  
100: R82         Shareholders' Equity of Xerox (Details)             HTML     76K  
101: R83         Other Comprehensive Income (Loss) - (Details)       HTML     79K  
102: R84         Other Comprehensive Income (Loss) - Accumulated     HTML     48K  
                Other Comprehensive Loss (Aocl) (Details)                        
103: R85         Earnings??(Loss) per Share - Computation of Basic   HTML     71K  
                and Diluted Earnings (Details)                                   
104: R86         Earnings??(Loss) per Share - Anti-Dilutive          HTML     41K  
                Securities (Details)                                             
105: R87         Contingencies and Litigation - Brazilian Tax        HTML     39K  
                Contingencies (Details)                                          
106: R88         Contingencies and Litigation - Other Pending        HTML     53K  
                Litigation (Details)                                             
107: R89         Subsequent Event (Details)                          HTML     44K  
109: XML         IDEA XML File -- Filing Summary                      XML    195K  
18: XML         XBRL Instance -- xrx-20210331_htm                    XML   4.22M 
108: EXCEL       IDEA Workbook of Financial Reports                  XLSX    137K  
14: EX-101.CAL  XBRL Calculations -- xrx-20210331_cal                XML    315K 
15: EX-101.DEF  XBRL Definitions -- xrx-20210331_def                 XML   1.09M 
16: EX-101.LAB  XBRL Labels -- xrx-20210331_lab                      XML   2.04M 
17: EX-101.PRE  XBRL Presentations -- xrx-20210331_pre               XML   1.29M 
13: EX-101.SCH  XBRL Schema -- xrx-20210331                          XSD    221K 
110: JSON        XBRL Instance as JSON Data -- MetaLinks              511±   720K  
111: ZIP         XBRL Zipped Folder -- 0001770450-21-000025-xbrl      Zip    730K  


‘10-Q’   —   Quarterly Report
Document Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"Part I -- Financial Information
"Item 1
"Financial Statements (Unaudited)
"Xerox Holdings Corporation Condensed Consolidated Statements of Income (Loss)
"Xerox Holdings Corporation Condensed Consolidated Statements of Comprehensive Income (Loss)
"Xerox Holdings Corporation Condensed Consolidated Balance Sheets
"Xerox Holdings Corporation Condensed Consolidated Statements of Cash Flows
"Xerox Corporation Condensed Consolidated Statements of Income (Loss)
"Xerox Corporation Condensed Consolidated Statements of Comprehensive Income (Loss)
"Xerox Corporation Condensed Consolidated Balance Sheets
"Xerox Corporation Condensed Consolidated Statements of Cash Flows
"Notes to Condensed Consolidated Financial Statements
"Item 2
"Management's Discussion and Analysis of Financial Condition and Results of Operations
"Capital Resources and Liquidity
"Financial Risk Management
"Non-GAAP Financial Measures
"Item 3
"Quantitative and Qualitative Disclosures About Market Risk
"Item 4
"Controls and Procedures
"Part II -- Other Information
"Legal Proceedings
"Item 1A
"Risk Factors
"Unregistered Sales of Equity Securities and Use of Proceeds
"Defaults Upon Senior Securities
"Mine Safety Disclosures
"Item 5
"Item 6
"Exhibits
"Signatures
"Exhibit Index

This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  xrx-20210331  
 i 0001770450 i 0000108772 i 12/31 i 2021 i Q1 i FALSE i P2Y i us-gaap:OtherAssetsNoncurrent i us-gaap:OtherAssetsNoncurrent i us-gaap:OtherLiabilitiesCurrent i us-gaap:OtherLiabilitiesCurrent i us-gaap:OtherLiabilitiesNoncurrent i us-gaap:OtherLiabilitiesNoncurrent00017704502021-01-012021-03-310001770450xrx:XeroxCorporationMember2021-01-012021-03-31xbrli:shares00017704502021-03-31iso4217:USD0001770450us-gaap:ProductMember2021-01-012021-03-310001770450us-gaap:ProductMember2020-01-012020-03-310001770450us-gaap:ServiceMember2021-01-012021-03-310001770450us-gaap:ServiceMember2020-01-012020-03-310001770450us-gaap:FinancialServiceMember2021-01-012021-03-310001770450us-gaap:FinancialServiceMember2020-01-012020-03-3100017704502020-01-012020-03-31iso4217:USDxbrli:shares00017704502020-12-3100017704502019-12-3100017704502020-03-310001770450xrx:XeroxCorporationMemberus-gaap:ProductMember2021-01-012021-03-310001770450xrx:XeroxCorporationMemberus-gaap:ProductMember2020-01-012020-03-310001770450xrx:XeroxCorporationMemberus-gaap:ServiceMember2021-01-012021-03-310001770450xrx:XeroxCorporationMemberus-gaap:ServiceMember2020-01-012020-03-310001770450xrx:XeroxCorporationMemberus-gaap:FinancialServiceMember2021-01-012021-03-310001770450xrx:XeroxCorporationMemberus-gaap:FinancialServiceMember2020-01-012020-03-310001770450xrx:XeroxCorporationMember2020-01-012020-03-310001770450xrx:XeroxCorporationMember2021-03-310001770450xrx:XeroxCorporationMember2020-12-310001770450xrx:XeroxCorporationMember2019-12-310001770450xrx:XeroxCorporationMember2020-03-31xbrli:pure0001770450srt:MinimumMember2020-10-012020-12-310001770450srt:MaximumMember2020-10-012020-12-310001770450country:US2021-01-012021-03-310001770450country:US2020-01-012020-03-310001770450srt:EuropeMember2021-01-012021-03-310001770450srt:EuropeMember2020-01-012020-03-310001770450country:CA2021-01-012021-03-310001770450country:CA2020-01-012020-03-310001770450xrx:OtherGeographicalMarketsMember2021-01-012021-03-310001770450xrx:OtherGeographicalMarketsMember2020-01-012020-03-310001770450us-gaap:ManufacturedProductOtherMember2021-01-012021-03-310001770450us-gaap:ManufacturedProductOtherMember2020-01-012020-03-310001770450xrx:SuppliesPaperAndOtherSalesMember2021-01-012021-03-310001770450xrx:SuppliesPaperAndOtherSalesMember2020-01-012020-03-310001770450us-gaap:MaintenanceMember2021-01-012021-03-310001770450us-gaap:MaintenanceMember2020-01-012020-03-310001770450xrx:ServiceArrangementsMember2021-01-012021-03-310001770450xrx:ServiceArrangementsMember2020-01-012020-03-310001770450xrx:RentalAndOtherMember2021-01-012021-03-310001770450xrx:RentalAndOtherMember2020-01-012020-03-310001770450xrx:SalesChannelDirectEquipmentLeaseMemberus-gaap:ProductMember2021-01-012021-03-310001770450xrx:SalesChannelDirectEquipmentLeaseMemberus-gaap:ProductMember2020-01-012020-03-310001770450us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:ProductMember2021-01-012021-03-310001770450us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:ProductMember2020-01-012020-03-310001770450us-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:ProductMember2021-01-012021-03-310001770450us-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:ProductMember2020-01-012020-03-310001770450xrx:ContractFulfillmentCostsandInducementsMember2021-03-310001770450xrx:ContractFulfillmentCostsandInducementsMember2020-12-310001770450xrx:ContractFulfillmentCostsandInducementsMember2021-01-012021-03-310001770450xrx:ContractFulfillmentCostsandInducementsMember2020-01-012020-03-310001770450us-gaap:OtherCurrentAssetsMember2021-03-310001770450us-gaap:OtherCurrentAssetsMember2020-12-310001770450us-gaap:OtherNoncurrentAssetsMember2021-03-310001770450us-gaap:OtherNoncurrentAssetsMember2020-12-310001770450us-gaap:AccountsReceivableMember2021-03-310001770450us-gaap:AccountsReceivableMember2020-12-310001770450us-gaap:AccountsReceivableMemberus-gaap:CreditConcentrationRiskMember2021-01-012021-03-310001770450us-gaap:AccountsReceivableMemberus-gaap:CreditConcentrationRiskMember2020-01-012020-12-310001770450us-gaap:AccountsReceivableMember2021-01-012021-03-310001770450us-gaap:AccountsReceivableMember2020-01-012020-03-310001770450us-gaap:FinanceReceivablesMemberus-gaap:CreditConcentrationRiskMember2021-01-012021-03-310001770450us-gaap:FinanceReceivablesMemberus-gaap:CreditConcentrationRiskMember2020-01-012020-12-310001770450xrx:COVID19PandemicMember2020-01-012020-03-310001770450country:US2020-12-310001770450country:CA2020-12-310001770450srt:EuropeMember2020-12-310001770450country:US2021-03-310001770450country:CA2021-03-310001770450srt:EuropeMember2021-03-310001770450country:US2019-12-310001770450country:CA2019-12-310001770450srt:EuropeMember2019-12-310001770450country:US2020-03-310001770450country:CA2020-03-310001770450srt:EuropeMember2020-03-310001770450us-gaap:RiskLevelLowMemberxrx:UnitedStatesDirectMember2021-03-310001770450us-gaap:RiskLevelMediumMemberxrx:UnitedStatesDirectMember2021-03-310001770450us-gaap:RiskLevelHighMemberxrx:UnitedStatesDirectMember2021-03-310001770450xrx:UnitedStatesDirectMember2021-03-310001770450us-gaap:RiskLevelLowMemberxrx:UnitedStatesIndirectMember2021-03-310001770450us-gaap:RiskLevelMediumMemberxrx:UnitedStatesIndirectMember2021-03-310001770450us-gaap:RiskLevelHighMemberxrx:UnitedStatesIndirectMember2021-03-310001770450xrx:UnitedStatesIndirectMember2021-03-310001770450us-gaap:RiskLevelLowMembercountry:CA2021-03-310001770450us-gaap:RiskLevelMediumMembercountry:CA2021-03-310001770450us-gaap:RiskLevelHighMembercountry:CA2021-03-310001770450us-gaap:RiskLevelLowMembersrt:EuropeMember2021-03-310001770450us-gaap:RiskLevelMediumMembersrt:EuropeMember2021-03-310001770450us-gaap:RiskLevelHighMembersrt:EuropeMember2021-03-310001770450us-gaap:RiskLevelLowMember2021-03-310001770450us-gaap:RiskLevelMediumMember2021-03-310001770450us-gaap:RiskLevelHighMember2021-03-310001770450us-gaap:RiskLevelLowMemberxrx:UnitedStatesDirectMember2020-12-310001770450us-gaap:RiskLevelMediumMemberxrx:UnitedStatesDirectMember2020-12-310001770450us-gaap:RiskLevelHighMemberxrx:UnitedStatesDirectMember2020-12-310001770450xrx:UnitedStatesDirectMember2020-12-310001770450us-gaap:RiskLevelLowMemberxrx:UnitedStatesIndirectMember2020-12-310001770450us-gaap:RiskLevelMediumMemberxrx:UnitedStatesIndirectMember2020-12-310001770450us-gaap:RiskLevelHighMemberxrx:UnitedStatesIndirectMember2020-12-310001770450xrx:UnitedStatesIndirectMember2020-12-310001770450us-gaap:RiskLevelLowMembercountry:CA2020-12-310001770450us-gaap:RiskLevelMediumMembercountry:CA2020-12-310001770450us-gaap:RiskLevelHighMembercountry:CA2020-12-310001770450us-gaap:RiskLevelLowMembersrt:EuropeMember2020-12-310001770450us-gaap:RiskLevelMediumMembersrt:EuropeMember2020-12-310001770450us-gaap:RiskLevelHighMembersrt:EuropeMember2020-12-310001770450us-gaap:RiskLevelLowMember2020-12-310001770450us-gaap:RiskLevelMediumMember2020-12-310001770450us-gaap:RiskLevelHighMember2020-12-310001770450xrx:DirectMemberus-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember2021-03-310001770450xrx:DirectMemberus-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember2021-03-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMemberxrx:DirectMemberus-gaap:BilledRevenuesMember2021-03-310001770450xrx:DirectMemberus-gaap:BilledRevenuesMember2021-03-310001770450xrx:DirectMemberus-gaap:UnbilledRevenuesMember2021-03-310001770450xrx:DirectMember2021-03-310001770450xrx:DirectMemberxrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2021-03-310001770450xrx:IndirectMemberus-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember2021-03-310001770450xrx:IndirectMemberus-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember2021-03-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMemberxrx:IndirectMemberus-gaap:BilledRevenuesMember2021-03-310001770450xrx:IndirectMemberus-gaap:BilledRevenuesMember2021-03-310001770450xrx:IndirectMemberus-gaap:UnbilledRevenuesMember2021-03-310001770450xrx:IndirectMember2021-03-310001770450xrx:IndirectMemberxrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2021-03-310001770450country:USus-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember2021-03-310001770450country:USus-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember2021-03-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMembercountry:USus-gaap:BilledRevenuesMember2021-03-310001770450country:USus-gaap:BilledRevenuesMember2021-03-310001770450country:USus-gaap:UnbilledRevenuesMember2021-03-310001770450country:USxrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2021-03-310001770450country:CAus-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember2021-03-310001770450country:CAus-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember2021-03-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMembercountry:CAus-gaap:BilledRevenuesMember2021-03-310001770450country:CAus-gaap:BilledRevenuesMember2021-03-310001770450country:CAus-gaap:UnbilledRevenuesMember2021-03-310001770450country:CAxrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2021-03-310001770450us-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMembersrt:EuropeMember2021-03-310001770450us-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMembersrt:EuropeMember2021-03-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMemberus-gaap:BilledRevenuesMembersrt:EuropeMember2021-03-310001770450us-gaap:BilledRevenuesMembersrt:EuropeMember2021-03-310001770450us-gaap:UnbilledRevenuesMembersrt:EuropeMember2021-03-310001770450srt:EuropeMemberxrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2021-03-310001770450us-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember2021-03-310001770450us-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember2021-03-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMemberus-gaap:BilledRevenuesMember2021-03-310001770450us-gaap:BilledRevenuesMember2021-03-310001770450us-gaap:UnbilledRevenuesMember2021-03-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2021-03-310001770450xrx:DirectMemberus-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember2020-12-310001770450xrx:DirectMemberus-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember2020-12-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMemberxrx:DirectMemberus-gaap:BilledRevenuesMember2020-12-310001770450xrx:DirectMemberus-gaap:BilledRevenuesMember2020-12-310001770450xrx:DirectMemberus-gaap:UnbilledRevenuesMember2020-12-310001770450xrx:DirectMember2020-12-310001770450xrx:DirectMemberxrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2020-12-310001770450xrx:IndirectMemberus-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember2020-12-310001770450xrx:IndirectMemberus-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember2020-12-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMemberxrx:IndirectMemberus-gaap:BilledRevenuesMember2020-12-310001770450xrx:IndirectMemberus-gaap:BilledRevenuesMember2020-12-310001770450xrx:IndirectMemberus-gaap:UnbilledRevenuesMember2020-12-310001770450xrx:IndirectMember2020-12-310001770450xrx:IndirectMemberxrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2020-12-310001770450country:USus-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember2020-12-310001770450country:USus-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember2020-12-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMembercountry:USus-gaap:BilledRevenuesMember2020-12-310001770450country:USus-gaap:BilledRevenuesMember2020-12-310001770450country:USus-gaap:UnbilledRevenuesMember2020-12-310001770450country:USxrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2020-12-310001770450country:CAus-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember2020-12-310001770450country:CAus-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember2020-12-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMembercountry:CAus-gaap:BilledRevenuesMember2020-12-310001770450country:CAus-gaap:BilledRevenuesMember2020-12-310001770450country:CAus-gaap:UnbilledRevenuesMember2020-12-310001770450country:CAxrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2020-12-310001770450us-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMembersrt:EuropeMember2020-12-310001770450us-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMembersrt:EuropeMember2020-12-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMemberus-gaap:BilledRevenuesMembersrt:EuropeMember2020-12-310001770450us-gaap:BilledRevenuesMembersrt:EuropeMember2020-12-310001770450us-gaap:UnbilledRevenuesMembersrt:EuropeMember2020-12-310001770450srt:EuropeMemberxrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2020-12-310001770450us-gaap:BilledRevenuesMemberxrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember2020-12-310001770450us-gaap:BilledRevenuesMemberxrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember2020-12-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMemberus-gaap:BilledRevenuesMember2020-12-310001770450us-gaap:BilledRevenuesMember2020-12-310001770450us-gaap:UnbilledRevenuesMember2020-12-310001770450xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember2020-12-310001770450xrx:SpecialPurposeEntitySPEMember2020-07-310001770450xrx:SecuredLoanAgreement1Memberxrx:SpecialPurposeEntitySPEMember2021-03-310001770450xrx:SpecialPurposeEntitySPEMember2020-12-310001770450xrx:SpecialPurposeEntitySPEMemberxrx:SecuredLoanAgreement2Member2021-03-31xrx:leasexrx:option0001770450us-gaap:EmployeeSeveranceMember2021-01-012021-03-31xrx:employee0001770450us-gaap:ContractTerminationMember2021-01-012021-03-310001770450xrx:RestructuringAssetImpairmentsMember2021-01-012021-03-310001770450us-gaap:EmployeeSeveranceMember2020-12-310001770450us-gaap:ContractTerminationMember2020-12-310001770450xrx:RestructuringAssetImpairmentsMember2020-12-310001770450us-gaap:EmployeeSeveranceMember2021-03-310001770450us-gaap:ContractTerminationMember2021-03-310001770450xrx:RestructuringAssetImpairmentsMember2021-03-310001770450xrx:RetentionRelatedSeveranceBonusesMember2021-01-012021-03-310001770450xrx:RetentionRelatedSeveranceBonusesMember2020-01-012020-03-310001770450xrx:ContractualSeveranceCostsMember2021-01-012021-03-310001770450xrx:ContractualSeveranceCostsMember2020-01-012020-03-310001770450xrx:ConsultingAndOtherCostsMember2021-01-012021-03-310001770450xrx:ConsultingAndOtherCostsMember2020-01-012020-03-310001770450xrx:HCLTechnologiesMember2021-01-012021-03-310001770450xrx:HCLTechnologiesMember2020-01-012020-03-310001770450xrx:A2025SeniorNotesMemberus-gaap:SeniorNotesMember2020-08-310001770450xrx:A2028SeniorNotesMemberus-gaap:SeniorNotesMember2020-08-310001770450xrx:A2025And2028SeniorNotesMemberus-gaap:SeniorNotesMember2020-08-012020-08-310001770450xrx:A2025SeniorNotesMemberus-gaap:SeniorNotesMember2020-08-240001770450xrx:A2028SeniorNotesMemberus-gaap:SeniorNotesMember2020-08-240001770450xrx:A2025And2028SeniorNotesMemberus-gaap:SeniorNotesMember2020-08-242020-08-240001770450xrx:A2025And2028SeniorNotesMemberxrx:XeroxHoldingsCorporationMemberus-gaap:SeniorNotesMember2020-08-012020-08-310001770450xrx:A2025And2028SeniorNotesMemberxrx:XeroxHoldingsCorporationMemberus-gaap:SeniorNotesMember2021-02-012021-02-280001770450xrx:A2025And2028SeniorNotesMemberus-gaap:SeniorNotesMember2021-03-310001770450xrx:A2020SeniorNotesMemberxrx:XeroxCorporationMemberus-gaap:SeniorNotesMember2021-01-012021-03-310001770450xrx:SpecialPurposeEntitySPEMemberxrx:SpecialPurposeEntitySPEMember2020-07-310001770450xrx:SpecialPurposeEntitySPEMember2020-07-310001770450xrx:SpecialPurposeEntitySPEMember2021-03-310001770450xrx:SpecialPurposeEntitySPEMember2021-03-310001770450xrx:SpecialPurposeEntitySPEMember2021-03-310001770450xrx:SpecialPurposeEntitySPEMember2020-12-310001770450us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-03-310001770450us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-12-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-03-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMember2021-03-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMember2020-12-310001770450us-gaap:OptionMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-03-310001770450us-gaap:OptionMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001770450us-gaap:DesignatedAsHedgingInstrumentMember2021-03-310001770450us-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMember2021-03-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMember2020-12-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2021-03-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2020-12-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2021-03-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2020-12-310001770450us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMember2021-01-012021-03-310001770450us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMember2020-01-012020-03-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2021-01-012021-03-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2020-01-012020-03-310001770450us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2021-01-012021-03-310001770450us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2020-01-012020-03-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:ForeignCurrencyGainLossMember2021-01-012021-03-310001770450us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:ForeignCurrencyGainLossMember2020-01-012020-03-310001770450us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeForwardMember2021-03-310001770450us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeForwardMember2020-12-310001770450us-gaap:OptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-03-310001770450us-gaap:OptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001770450us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-03-310001770450us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001770450us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-03-310001770450us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-03-310001770450us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2020-12-310001770450us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2020-12-310001770450xrx:XeroxHoldingsCorporationMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-03-310001770450xrx:XeroxHoldingsCorporationMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-03-310001770450xrx:XeroxHoldingsCorporationMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2020-12-310001770450xrx:XeroxHoldingsCorporationMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2020-12-310001770450xrx:XeroxCorporationMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-03-310001770450us-gaap:EstimateOfFairValueFairValueDisclosureMemberxrx:XeroxCorporationMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-03-310001770450xrx:XeroxCorporationMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2020-12-310001770450us-gaap:EstimateOfFairValueFairValueDisclosureMemberxrx:XeroxCorporationMemberus-gaap:FairValueMeasurementsNonrecurringMember2020-12-310001770450xrx:OtherSubsidiariesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-03-310001770450xrx:OtherSubsidiariesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-03-310001770450xrx:OtherSubsidiariesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2020-12-310001770450xrx:OtherSubsidiariesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2020-12-310001770450us-gaap:PensionPlansDefinedBenefitMembercountry:US2021-01-012021-03-310001770450us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-01-012020-03-310001770450us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2021-01-012021-03-310001770450us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-01-012020-03-310001770450us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-03-310001770450us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-03-310001770450us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001770450us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-01-012020-12-310001770450us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-12-310001770450us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-01-012020-12-310001770450us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-03-310001770450us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-03-310001770450us-gaap:PensionPlansDefinedBenefitMember2020-12-310001770450us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001770450us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001770450us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310001770450us-gaap:PensionPlansDefinedBenefitMemberus-gaap:QualifiedPlanMembercountry:US2021-03-310001770450srt:ScenarioForecastMember2021-01-012021-12-310001770450us-gaap:CommonStockMember2020-12-310001770450us-gaap:AdditionalPaidInCapitalMember2020-12-310001770450us-gaap:TreasuryStockMember2020-12-310001770450us-gaap:RetainedEarningsMember2020-12-310001770450us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001770450us-gaap:ParentMember2020-12-310001770450us-gaap:NoncontrollingInterestMember2020-12-310001770450us-gaap:RetainedEarningsMember2021-01-012021-03-310001770450us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001770450us-gaap:ParentMember2021-01-012021-03-310001770450us-gaap:NoncontrollingInterestMember2021-01-012021-03-310001770450us-gaap:CommonStockMember2021-01-012021-03-310001770450us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001770450us-gaap:TreasuryStockMember2021-01-012021-03-310001770450us-gaap:CommonStockMember2021-03-310001770450us-gaap:AdditionalPaidInCapitalMember2021-03-310001770450us-gaap:TreasuryStockMember2021-03-310001770450us-gaap:RetainedEarningsMember2021-03-310001770450us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001770450us-gaap:ParentMember2021-03-310001770450us-gaap:NoncontrollingInterestMember2021-03-310001770450us-gaap:CommonStockMember2019-12-310001770450us-gaap:AdditionalPaidInCapitalMember2019-12-310001770450us-gaap:TreasuryStockMember2019-12-310001770450us-gaap:RetainedEarningsMember2019-12-310001770450us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001770450us-gaap:ParentMember2019-12-310001770450us-gaap:NoncontrollingInterestMember2019-12-310001770450us-gaap:RetainedEarningsMember2020-01-012020-03-310001770450us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001770450us-gaap:ParentMember2020-01-012020-03-310001770450us-gaap:NoncontrollingInterestMember2020-01-012020-03-310001770450us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001770450us-gaap:CommonStockMember2020-01-012020-03-310001770450us-gaap:TreasuryStockMember2020-01-012020-03-310001770450us-gaap:CommonStockMember2020-03-310001770450us-gaap:AdditionalPaidInCapitalMember2020-03-310001770450us-gaap:TreasuryStockMember2020-03-310001770450us-gaap:RetainedEarningsMember2020-03-310001770450us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001770450us-gaap:ParentMember2020-03-310001770450us-gaap:NoncontrollingInterestMember2020-03-310001770450xrx:XeroxCorporationMemberus-gaap:AdditionalPaidInCapitalMember2020-12-310001770450xrx:XeroxCorporationMemberus-gaap:RetainedEarningsMember2020-12-310001770450xrx:XeroxCorporationMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001770450xrx:XeroxCorporationMemberus-gaap:ParentMember2020-12-310001770450xrx:XeroxCorporationMemberus-gaap:NoncontrollingInterestMember2020-12-310001770450xrx:XeroxCorporationMemberus-gaap:RetainedEarningsMember2021-01-012021-03-310001770450xrx:XeroxCorporationMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001770450xrx:XeroxCorporationMemberus-gaap:ParentMember2021-01-012021-03-310001770450xrx:XeroxCorporationMemberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001770450xrx:XeroxCorporationMemberus-gaap:AdditionalPaidInCapitalMember2021-03-310001770450xrx:XeroxCorporationMemberus-gaap:RetainedEarningsMember2021-03-310001770450xrx:XeroxCorporationMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001770450xrx:XeroxCorporationMemberus-gaap:ParentMember2021-03-310001770450xrx:XeroxCorporationMemberus-gaap:NoncontrollingInterestMember2021-03-310001770450xrx:XeroxCorporationMemberus-gaap:AdditionalPaidInCapitalMember2019-12-310001770450xrx:XeroxCorporationMemberus-gaap:RetainedEarningsMember2019-12-310001770450xrx:XeroxCorporationMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001770450xrx:XeroxCorporationMemberus-gaap:ParentMember2019-12-310001770450xrx:XeroxCorporationMemberus-gaap:NoncontrollingInterestMember2019-12-310001770450xrx:XeroxCorporationMemberus-gaap:RetainedEarningsMember2020-01-012020-03-310001770450xrx:XeroxCorporationMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001770450xrx:XeroxCorporationMemberus-gaap:ParentMember2020-01-012020-03-310001770450xrx:XeroxCorporationMemberus-gaap:NoncontrollingInterestMember2020-01-012020-03-310001770450xrx:XeroxCorporationMemberus-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001770450xrx:XeroxCorporationMemberus-gaap:AdditionalPaidInCapitalMember2020-03-310001770450xrx:XeroxCorporationMemberus-gaap:RetainedEarningsMember2020-03-310001770450xrx:XeroxCorporationMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001770450xrx:XeroxCorporationMemberus-gaap:ParentMember2020-03-310001770450xrx:XeroxCorporationMemberus-gaap:NoncontrollingInterestMember2020-03-310001770450us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-03-310001770450us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-03-310001770450us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-03-310001770450us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-01-012020-03-310001770450us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-01-012021-03-310001770450us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2020-01-012020-03-310001770450us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2021-01-012021-03-310001770450us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2020-01-012020-03-310001770450xrx:AccumulatedDefinedBenefitPlansAdjustmentActuarialLossAmortizationAndSettlementAttributableToParentMember2021-01-012021-03-310001770450xrx:AccumulatedDefinedBenefitPlansAdjustmentActuarialLossAmortizationAndSettlementAttributableToParentMember2020-01-012020-03-310001770450xrx:AccumulatedDefinedBenefitPlansAdjustmentOtherAttributableToParentMember2021-01-012021-03-310001770450xrx:AccumulatedDefinedBenefitPlansAdjustmentOtherAttributableToParentMember2020-01-012020-03-310001770450us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-03-310001770450us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-03-310001770450us-gaap:AccumulatedTranslationAdjustmentMember2021-03-310001770450us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001770450xrx:OtherAccumulatedGainLossAttributableToParentMember2021-03-310001770450xrx:OtherAccumulatedGainLossAttributableToParentMember2020-12-310001770450us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-03-310001770450us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001770450us-gaap:EmployeeStockOptionMember2021-01-012021-03-310001770450us-gaap:EmployeeStockOptionMember2020-01-012020-03-310001770450xrx:RestrictedStockAndPerformanceSharesMember2021-01-012021-03-310001770450xrx:RestrictedStockAndPerformanceSharesMember2020-01-012020-03-310001770450us-gaap:ConvertiblePreferredStockMember2021-01-012021-03-310001770450us-gaap:ConvertiblePreferredStockMember2020-01-012020-03-310001770450us-gaap:EmployeeStockOptionMember2021-01-012021-03-310001770450us-gaap:EmployeeStockOptionMember2020-01-012020-03-310001770450xrx:RestrictedStockAndPerformanceSharesMember2021-01-012021-03-310001770450xrx:RestrictedStockAndPerformanceSharesMember2020-01-012020-03-310001770450us-gaap:ConvertiblePreferredStockMember2021-01-012021-03-310001770450us-gaap:ConvertiblePreferredStockMember2020-01-012020-03-310001770450xrx:BrazilContingenciesMember2021-03-310001770450xrx:BrazilContingenciesMember2020-12-310001770450us-gaap:SubsequentEventMemberxrx:RibbeVJacobsonEtAlMember2021-04-072021-04-070001770450xrx:HPInc.Memberxrx:MiamiFirefightersReliefPensionFundVIcahnEtAlMember2019-12-132019-12-130001770450xrx:XeroxHoldingsCorporationMember2021-03-100001770450xrx:XeroxHoldingsCorporationMember2020-01-012020-12-31xrx:request00017704502021-03-100001770450us-gaap:PerformanceGuaranteeMember2021-03-310001770450us-gaap:SubsequentEventMemberus-gaap:TrademarksMember2021-04-012021-04-300001770450us-gaap:SubsequentEventMember2021-04-300001770450us-gaap:SubsequentEventMember2021-04-012021-04-300001770450us-gaap:SubsequentEventMemberxrx:OfficeEquipmentDealerMember2021-04-012021-04-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM  i 10-Q
(Mark One)
 i QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended:  i March 31, 2021
 i TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                        to
xrx-20210331_g1.jpg
 i XEROX HOLDINGS CORPORATION
 i XEROX CORPORATION
 (Exact Name of Registrant as specified in its charter)

 i New York i 001-39013 i 83-3933743
 i New York i 001-04471 i 16-0468020
(State or other jurisdiction of incorporation or organization)(Commission File Number)(IRS Employer Identification No.)
 i P.O. Box 4505,  i 201 Merritt 7
 i Norwalk,  i Connecticut  i 06851-1056
(Address of principal executive offices)
 i (203)  i 849-5216
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
 i Common Stock, $1 par value i XRX i New York Stock Exchange
Title of each classTrading SymbolName of each exchange on which registered
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Xerox Holdings Corporation  i Yes  No               Xerox Corporation  i Yes  No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 
Xerox Holdings Corporation  i Yes  No               Xerox Corporation  i Yes  No 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.            
Xerox Holdings CorporationXerox Corporation
 i Large accelerated filerLarge accelerated filer
Accelerated filerAccelerated filer
Non-accelerated filer i Non-accelerated filer
Smaller reporting company i Smaller reporting company i 
Emerging growth company i Emerging growth company i 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Xerox Holdings Corporation o      Xerox Corporation o
Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Xerox Holdings Corporation Yes  i  No               Xerox Corporation Yes  i  No 
Class Outstanding at March 31, 2021
Xerox Holdings Corporation Common Stock, $1 par value  i 191,947,343 shares




CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This document, and other written or oral statements made from time to time by management contain “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. The words “anticipate”, “believe”, “estimate”, “expect”, “intend”, “will”, “should”, “targeting”, “projecting”, “driving” and similar expressions, as they relate to us, our performance and/or our technology, are intended to identify forward-looking statements. These statements reflect management’s current beliefs, assumptions and expectations and are subject to a number of factors that may cause actual results to differ materially. Such factors include but are not limited to: the effects of the COVID-19 pandemic on our and our customers' businesses and the duration and extent to which this will impact our future results of operations and overall financial performance; our ability to address our business challenges in order to reverse revenue declines, reduce costs and increase productivity so that we can invest in and grow our business; our ability to attract and retain key personnel; changes in economic and political conditions, trade protection measures, licensing requirements and tax laws in the United States and in the foreign countries in which we do business; the imposition of new or incremental trade protection measures such as tariffs and import or export restrictions; changes in foreign currency exchange rates; our ability to successfully develop new products, technologies and service offerings and to protect our intellectual property rights; the risk that multi-year contracts with governmental entities could be terminated prior to the end of the contract term and that civil or criminal penalties and administrative sanctions could be imposed on us if we fail to comply with the terms of such contracts and applicable law; the risk that partners, subcontractors and software vendors will not perform in a timely, quality manner; actions of competitors and our ability to promptly and effectively react to changing technologies and customer expectations; our ability to obtain adequate pricing for our products and services and to maintain and improve cost efficiency of operations, including savings from restructuring actions; the risk that confidential and/or individually identifiable information of ours, our customers, clients and employees could be inadvertently disclosed or disclosed as a result of a breach of our security systems due to cyber attacks or other intentional acts; reliance on third parties, including subcontractors, for manufacturing of products and provision of services; the exit of the United Kingdom from the European Union; our ability to manage changes in the printing environment and expand equipment placements; interest rates, cost of borrowing and access to credit markets; funding requirements associated with our employee pension and retiree health benefit plans; the risk that our operations and products may not comply with applicable worldwide regulatory requirements, particularly environmental regulations and directives and anti-corruption laws; the outcome of litigation and regulatory proceedings to which we may be a party; any impacts resulting from the restructuring of our relationship with Fujifilm Holdings Corporation; and the shared services arrangements entered into by us as part of Project Own It. Additional risks that may affect Xerox’s operations and other factors that are set forth in the “Risk Factors” section, the “Legal Proceedings” section, the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section and other sections of this combined Quarterly Report on Form 10-Q and Xerox Holdings Corporation’s and Xerox Corporation’s combined 2020 Annual Report on Form 10-K, as well as in Xerox Holdings Corporation’s and Xerox Corporation’s Current Reports on Form 8-K filed with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this document or as of the date to which they refer, and Xerox assumes no obligation to update any forward-looking statements as a result of new information or future events or developments, except as required by law.
Throughout this combined Quarterly Report on Form 10-Q ("combined Form 10-Q"), references to “Xerox Holdings” refer to Xerox Holdings Corporation and its consolidated subsidiaries while references to “Xerox” refer to Xerox Corporation and its consolidated subsidiaries. References herein to “we,” “us,” “our,” the “Company” refer collectively to both Xerox Holdings and Xerox unless the context suggests otherwise. References to “Xerox Holdings Corporation” refer to the stand-alone parent company and do not include its subsidiaries. References to “Xerox Corporation” refer to the stand-alone company and do not include subsidiaries.
Xerox Holdings Corporation's primary direct operating subsidiary is Xerox and therefore Xerox reflects nearly all of Xerox Holdings' operations.

Xerox 2021 Form 10-Q 1


XEROX HOLDINGS CORPORATION
XEROX CORPORATION
FORM 10-Q
March 31, 2021
TABLE OF CONTENTS
 
 Page
For additional information about Xerox Holdings Corporation and Xerox Corporation and access to our Annual Reports to Shareholders and SEC filings, free of charge, please visit our website at www.xerox.com/investor. The content of our website is not incorporated by reference into this combined Form 10-Q unless expressly noted.
 
Xerox 2021 Form 10-Q 2


PART I — FINANCIAL INFORMATION
ITEM 1 — FINANCIAL STATEMENTS

XEROX HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (UNAUDITED)

 Three Months Ended
March 31,
(in millions, except per-share data)20212020
Revenues
Sales$ i 602 $ i 565 
Services, maintenance and rentals i 1,053  i 1,236 
Financing i 55  i 59 
Total Revenues i 1,710  i 1,860 
Costs and Expenses
Cost of sales i 420  i 387 
Cost of services, maintenance and rentals i 651  i 731 
Cost of financing i 28  i 30 
Research, development and engineering expenses i 74  i 84 
Selling, administrative and general expenses i 448  i 541 
Restructuring and related costs, net i 17  i 41 
Amortization of intangible assets i 15  i 11 
Transaction and related costs, net i   i 17 
Other expenses, net i 4  i 23 
Total Costs and Expenses i 1,657  i 1,865 
Income (Loss) before Income Taxes and Equity Income i 53 ( i 5)
Income tax expense (benefit) i 14 ( i 1)
Equity in net income of unconsolidated affiliates i   i 2 
Net Income (Loss) i 39 ( i 2)
Less: Net income attributable to noncontrolling interests i   i  
Net Income (Loss) Attributable to Xerox Holdings$ i 39 $( i 2)
Basic Earnings (Loss) per Share$ i 0.18 $( i 0.03)
Diluted Earnings (Loss) per Share$ i 0.18 $( i 0.03)



The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
Xerox 2021 Form 10-Q 3


XEROX HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

 Three Months Ended
March 31,
(in millions)20212020
Net Income (Loss)$ i 39 $( i 2)
Less: Net income attributable to noncontrolling interests i   i  
Net Income (Loss) Attributable to Xerox Holdings i 39 ( i 2)
Other Comprehensive (Loss) Income, Net(1)
Translation adjustments, net( i 51)( i 197)
Unrealized (losses) gains, net( i 7) i 5 
Changes in defined benefit plans, net i 55  i 54 
Other Comprehensive Loss, Net Attributable to Xerox Holdings( i 3)( i 138)
Comprehensive Income (Loss), Net Attributable to Xerox Holdings$ i 36 $( i 140)
_____________
(1) Refer to Note 17 - Other Comprehensive Income (Loss) for gross components of Other comprehensive loss, net, reclassification adjustments out of Accumulated other comprehensive loss and related tax effects.




The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Xerox 2021 Form 10-Q 4


XEROX HOLDINGS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(in millions, except share data in thousands)March 31,
2021
December 31,
2020
Assets
Cash and cash equivalents$ i 2,379 $ i 2,625 
Accounts receivable (net of allowance of $ i 68 and $ i 69, respectively)
 i 781  i 883 
Billed portion of finance receivables (net of allowance of $ i 4 and $ i 4, respectively)
 i 92  i 99 
Finance receivables, net i 1,065  i 1,082 
Inventories i 841  i 843 
Other current assets i 262  i 251 
Total current assets i 5,420  i 5,783 
Finance receivables due after one year (net of allowance of $ i 131 and $ i 129, respectively)
 i 1,920  i 1,984 
Equipment on operating leases, net i 277  i 296 
Land, buildings and equipment, net i 393  i 407 
Intangible assets, net i 223  i 237 
Goodwill i 4,075  i 4,071 
Deferred tax assets i 510  i 508 
Other long-term assets i 1,454  i 1,455 
Total Assets$ i 14,272 $ i 14,741 
Liabilities and Equity
Short-term debt and current portion of long-term debt$ i 678 $ i 394 
Accounts payable i 932  i 983 
Accrued compensation and benefits costs i 241  i 261 
Accrued expenses and other current liabilities i 794  i 840 
Total current liabilities i 2,645  i 2,478 
Long-term debt i 3,674  i 4,050 
Pension and other benefit liabilities i 1,473  i 1,566 
Post-retirement medical benefits i 339  i 340 
Other long-term liabilities i 498  i 497 
Total Liabilities i 8,629  i 8,931 
Commitments and Contingencies (See Note 19) i  i 
Convertible Preferred Stock i 214  i 214 
Common stock i 199  i 198 
Additional paid-in capital i 2,456  i 2,445 
Treasury stock, at cost( i 162) i  
Retained earnings i 6,267  i 6,281 
Accumulated other comprehensive loss( i 3,335)( i 3,332)
Xerox Holdings shareholders’ equity i 5,425  i 5,592 
Noncontrolling interests i 4  i 4 
Total Equity i 5,429  i 5,596 
Total Liabilities and Equity$ i 14,272 $ i 14,741 
Shares of common stock issued i 198,651  i 198,386 
Treasury stock( i 6,704) i  
Shares of Common Stock Outstanding i 191,947  i 198,386 
.


The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
Xerox 2021 Form 10-Q 5


XEROX HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 Three Months Ended
March 31,
(in millions)20212020
Cash Flows from Operating Activities
Net Income (Loss)$ i 39 $( i 2)
Adjustments required to reconcile Net income (loss) to Cash flows from operating activities
Depreciation and amortization i 86  i 94 
Provisions i 20  i 80 
Net gain on sales of businesses and assets i  ( i 1)
Stock-based compensation i 16  i 11 
Restructuring and asset impairment charges i 21  i 29 
Payments for restructurings( i 27)( i 35)
Defined benefit pension cost i   i 24 
Contributions to defined benefit pension plans( i 35)( i 33)
Decrease in accounts receivable and billed portion of finance receivables i 92  i 166 
Increase in inventories( i 18)( i 126)
Increase in equipment on operating leases( i 28)( i 32)
Decrease in finance receivables i 37  i 93 
Decrease (increase) in other current and long-term assets i 18 ( i 16)
(Decrease) increase in accounts payable( i 31) i 51 
Decrease in accrued compensation( i 36)( i 108)
Decrease in other current and long-term liabilities( i 35)( i 38)
Net change in income tax assets and liabilities i 6 ( i 10)
Net change in derivative assets and liabilities i 3  i 8 
Other operating, net( i 11) i 18 
Net cash provided by operating activities i 117  i 173 
Cash Flows from Investing Activities
Cost of additions to land, buildings, equipment and software( i 17)( i 23)
Proceeds from sales of businesses and assets i   i 2 
Acquisitions, net of cash acquired i  ( i 193)
Net cash used in investing activities( i 17)( i 214)
Cash Flows from Financing Activities
Proceeds from issuance of long-term debt i   i 2 
Payments on long-term debt( i 95) i  
Dividends( i 54)( i 58)
Payments to acquire treasury stock, including fees( i 162) i  
Other financing, net( i 7)( i 4)
Net cash used in financing activities( i 318)( i 60)
Effect of exchange rate changes on cash, cash equivalents and restricted cash( i 12)( i 29)
Decrease in cash, cash equivalents and restricted cash( i 230)( i 130)
Cash, cash equivalents and restricted cash at beginning of period i 2,691  i 2,795 
Cash, Cash Equivalents and Restricted Cash at End of Period$ i 2,461 $ i 2,665 





The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
Xerox 2021 Form 10-Q 6


XEROX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (UNAUDITED)
 Three Months Ended
March 31,
(in millions)20212020
Revenues
Sales$ i 602 $ i 565 
Services, maintenance and rentals i 1,053  i 1,236 
Financing i 55  i 59 
Total Revenues i 1,710  i 1,860 
Costs and Expenses
Cost of sales i 420  i 387 
Cost of services, maintenance and rentals i 651  i 731 
Cost of financing i 28  i 30 
Research, development and engineering expenses i 74  i 84 
Selling, administrative and general expenses i 447  i 541 
Restructuring and related costs, net i 17  i 41 
Amortization of intangible assets i 14  i 11 
Transaction and related costs, net i   i 17 
Other expenses, net i 4  i 23 
Total Costs and Expenses i 1,655  i 1,865 
Income (Loss) before Income Taxes and Equity Income i 55 ( i 5)
Income tax expense (benefit) i 14 ( i 1)
Equity in net income of unconsolidated affiliates i   i 2 
Net Income (Loss) i 41 ( i 2)
Less: Net income attributable to noncontrolling interests i   i  
Net Income (Loss) Attributable to Xerox$ i 41 $( i 2)









The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Xerox 2021 Form 10-Q 7


XEROX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

 Three Months Ended
March 31,
(in millions)20212020
Net Income (Loss)$ i 41 $( i 2)
Less: Net income attributable to noncontrolling interests i   i  
Net Income (Loss) Attributable to Xerox i 41 ( i 2)
Other Comprehensive (Loss) Income, Net(1)
Translation adjustments, net( i 51)( i 197)
Unrealized (losses) gains, net( i 7) i 5 
Changes in defined benefit plans, net i 55  i 54 
Other Comprehensive Loss, Net Attributable to Xerox( i 3)( i 138)
Comprehensive Income (Loss), Net Attributable to Xerox$ i 38 $( i 140)
_____________
(1) Refer to Note 17 - Other Comprehensive Income (Loss) for gross components of Other comprehensive loss, net, reclassification adjustments out of Accumulated other comprehensive loss and related tax effects.



The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Xerox 2021 Form 10-Q 8


XEROX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(in millions)March 31,
2021
December 31,
2020
Assets
Cash and cash equivalents$ i 2,379 $ i 2,625 
Accounts receivable (net of allowance of $ i 68 and $ i 69, respectively)
 i 781  i 883 
Billed portion of finance receivables (net of allowance of $ i 4 and $ i 4, respectively)
 i 92  i 99 
Finance receivables, net i 1,065  i 1,082 
Inventories i 841  i 843 
Other current assets i 263  i 251 
Total current assets i 5,421  i 5,783 
Finance receivables due after one year (net of allowance of $ i 131 and $ i 129, respectively)
 i 1,920  i 1,984 
Equipment on operating leases, net i 277  i 296 
Land, buildings and equipment, net i 393  i 407 
Intangible assets, net i 216  i 229 
Goodwill i 4,072  i 4,068 
Deferred tax assets i 510  i 508 
Other long-term assets i 1,455  i 1,455 
Total Assets$ i 14,264 $ i 14,730 
Liabilities and Equity
Short-term debt and current portion of long-term debt$ i 678 $ i 394 
Accounts payable i 932  i 983 
Accrued compensation and benefits costs i 241  i 261 
Accrued expenses and other current liabilities i 736  i 750 
Total current liabilities i 2,587  i 2,388 
Long-term debt i 2,180  i 2,557 
Related party debt i 1,494  i  
Pension and other benefit liabilities i 1,473  i 1,566 
Post-retirement medical benefits i 339  i 340 
Other long-term liabilities i 497  i 494 
Total Liabilities i 8,570  i 7,345 
Commitments and Contingencies (See Note 19) i  i 
Additional paid-in capital i 3,351  i 4,879 
Retained earnings i 5,674  i 5,834 
Accumulated other comprehensive loss( i 3,335)( i 3,332)
Xerox shareholder's equity i 5,690  i 7,381 
Noncontrolling interests i 4  i 4 
Total Equity i 5,694  i 7,385 
Total Liabilities and Equity$ i 14,264 $ i 14,730 





The accompanying notes are an integral part of these Condensed Consolidated Financial Statements. 
Xerox 2021 Form 10-Q 9


XEROX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 Three Months Ended
March 31,
(in millions)20212020
Cash Flows from Operating Activities
Net Income (Loss)$ i 41 $( i 2)
Adjustments required to reconcile Net income (loss) to Cash flows from operating activities
Depreciation and amortization i 85  i 94 
Provisions i 20  i 80 
Net gain on sales of businesses and assets i  ( i 1)
Stock-based compensation i 16  i 11 
Restructuring and asset impairment charges i 21  i 29 
Payments for restructurings( i 27)( i 35)
Defined benefit pension cost i   i 24 
Contributions to defined benefit pension plans( i 35)( i 33)
Decrease in accounts receivable and billed portion of finance receivables i 92  i 166 
Increase in inventories( i 18)( i 126)
Increase in equipment on operating leases( i 28)( i 32)
Decrease in finance receivables i 37  i 93 
Decrease (increase) in other current and long-term assets i 18 ( i 16)
(Decrease) increase in accounts payable( i 31) i 51 
Decrease in accrued compensation( i 36)( i 108)
Decrease in other current and long-term liabilities( i 36)( i 38)
Net change in income tax assets and liabilities i 6 ( i 10)
Net change in derivative assets and liabilities i 3  i 8 
Other operating, net( i 11) i 18 
Net cash provided by operating activities i 117  i 173 
Cash Flows from Investing Activities
Cost of additions to land, buildings, equipment and software( i 17)( i 23)
Proceeds from sales of businesses and assets i   i 2 
Acquisitions, net of cash acquired i  ( i 193)
Net cash used in investing activities( i 17)( i 214)
Cash Flows from Financing Activities
Proceeds from issuance of long-term debt i   i 2 
Payments on long-term debt( i 95) i  
Distributions to parent( i 220)( i 58)
Other financing, net( i 3)( i 4)
Net cash used in financing activities( i 318)( i 60)
Effect of exchange rate changes on cash, cash equivalents and restricted cash( i 12)( i 29)
Decrease in cash, cash equivalents and restricted cash( i 230)( i 130)
Cash, cash equivalents and restricted cash at beginning of period i 2,691  i 2,795 
Cash, Cash Equivalents and Restricted Cash at End of Period$ i 2,461 $ i 2,665 


The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
Xerox 2021 Form 10-Q 10


XEROX HOLDINGS CORPORATION
XEROX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(in millions, except per-share data and where otherwise noted)

Note 1 –  i Basis of Presentation
References to “Xerox Holdings” refer to Xerox Holdings Corporation and its consolidated subsidiaries while references to “Xerox” refer to Xerox Corporation and its consolidated subsidiaries. References herein to “we,” “us,” “our,” the “Company” refer collectively to both Xerox Holdings and Xerox unless the context suggests otherwise. References to "Xerox Holdings Corporation" refer to the stand-alone parent company and do not include its subsidiaries. References to "Xerox Corporation" refer to the stand-alone company and do not include its subsidiaries.

The accompanying unaudited Condensed Consolidated Financial Statements and footnotes represent the respective, consolidated results and financial results of Xerox Holdings and Xerox and all respective companies that each registrant directly or indirectly controls, either through majority ownership or otherwise. This is a combined report of Xerox Holdings and Xerox, which includes separate unaudited Condensed Consolidated Financial Statements for each registrant.
The accompanying unaudited Condensed Consolidated Financial Statements of both Xerox Holdings and Xerox have been prepared in accordance with the accounting policies described in the Combined 2020 Annual Report on Form 10-K ("2020 Annual Report"), except as noted herein, and the interim reporting requirements of Form 10-Q. Accordingly, certain information and note disclosures normally included in our annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. You should read these Condensed Consolidated Financial Statements in conjunction with the Consolidated Financial Statements included in the Combined 2020 Annual Report.
In our opinion, all adjustments, which are necessary for a fair statement of financial position, operating results and cash flows for the interim periods presented, have been made. These adjustments consist of normal recurring items. Interim results of operations are not necessarily indicative of the results of the full year.
As of March 31, 2021, although we did see certain improvement in our financial results as businesses gained confidence in the progress to control the COVID-19 pandemic and resumed investments in new printing technology and services, the pandemic continues to progress and impact our financial results. Accordingly, many of our estimates and assumptions continue to require an increased level of judgment and may have to change in the future as events continue to evolve and additional information becomes available.
For convenience and ease of reference, we refer to the financial statement caption “Income (Loss) before Income Taxes and Equity Income” as “pre-tax income (loss)”.
Notes to the Condensed Consolidated Financial Statements reflect the activity for both Xerox Holdings and Xerox for all periods presented, unless otherwise noted.
Goodwill
Interim Impairment Evaluation
We perform our annual goodwill impairment testing in the fourth quarter of each year. After completing our quantitative impairment review in the fourth quarter 2020, we concluded that Goodwill was not impaired. Based on various forecast models, which we believe reflected the inherent uncertainty of the future, we estimated that the excess of fair value over carrying value ranged between  i 15% and  i 20%.
During the quarter ended March 31, 2021, although business performance continues to improve, we determined that the continued negative impacts on our current operations resulting from the COVID-19 pandemic as well as a market capitalization that remains less than book value required us to qualitatively assess whether a triggering event had occurred and whether it was more likely than not that our goodwill was impaired as of March 31, 2021. Based on our interim qualitative assessment as of March 31, 2021, we determined that it was more-likely-than-not that the fair value of the Company was greater than the net book value and that we did not have a “triggering event” requiring a quantitative or Step 1 assessment of goodwill. Our review of macroeconomic and industry considerations, as well as the Company's financial results for the first quarter 2021 and projections for the full year 2021, were consistent with the expectations and sensitivities assessed as part of our review performed in the fourth
Xerox 2021 Form 10-Q 11


quarter 2020. Further, although our market capitalization remained below our net book value, the Company's market capitalization did improve in the first quarter 2021.
If assumptions or estimates in the fair value calculations change or if future cash flows vary from what was expected, including those assumptions relating to the duration and severity of the financial impact from the COVID-19 pandemic, this may impact the impairment analysis and could reduce the underlying cash flows used to estimate fair values and result in a decline in fair value that may trigger future impairment charges.
Note 2 –  i Recent Accounting Pronouncements
Xerox Holdings and Xerox consider the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). The ASUs listed below apply to both registrants. ASUs not listed below were assessed and determined to be not applicable to the Condensed Consolidated Financial Statements of either registrant.
 i 
Accounting Standard Updates to be Adopted:
Debt
In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40). This update simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments and convertible preferred stock. This update also amends the guidance for the derivatives scope exception for contracts in an entity's own equity to reduce form-over-substance-based accounting conclusions and requires the application of the if-converted method for calculating diluted earnings per share. This update is effective for our fiscal year beginning January 1, 2022. We are currently evaluating the impact of the adoption of this standard on the Company’s consolidated financial statements and related disclosures.
Reference Rate Reform
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or by another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which provided clarification guidance to ASU 2020-04. These ASUs were effective commencing with our quarter ended March 31, 2020 through December 31, 2022. There has been no impact to date as a result of ASU 2020-04 or ASU 2021-01 and subsequent amendments on reference rate reform, however we continue to evaluate potential future impacts that may result from the discontinuation of LIBOR or other reference rates as well as the accounting provided in this update on our financial condition, results of operations, and cash flows.
Accounting Standard Updates Adopted in 2021:
Income Taxes
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which was intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. We adopted this update effective for our fiscal year beginning January 1, 2021. The adoption did not have nor is expected to have a material impact on our results of operations, financial position or disclosures.
Other Updates
In 2021 and 2020, the FASB also issued the following ASUs, which impact the Company but did not have or are not expected to have a material impact on our financial condition, results of operations or cash flows upon adoption. Those updates are as follows:
Investments: ASU 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323) and Derivatives and Hedging (Topic 815). This update is effective for our fiscal year beginning January 1, 2021.
Xerox 2021 Form 10-Q 12


Note 3 –  i Revenue
 i 
Revenues disaggregated by primary geographic markets, major product lines, and sales channels are as follows:
Three Months Ended
March 31,
20212020
Primary geographical markets(1):
United States$ i 974 $ i 1,114 
Europe i 499  i 481 
Canada i 93  i 108 
Other i 144  i 157 
Total Revenues$ i 1,710 $ i 1,860 
Major product and services lines:
Equipment$ i 381 $ i 325 
Supplies, paper and other sales i 221  i 240 
Maintenance agreements(2)
 i 435  i 529 
Service arrangements(3)
 i 489  i 566 
Rental and other i 129  i 141 
Financing i 55  i 59 
Total Revenues$ i 1,710 $ i 1,860 
Sales channels:
Direct equipment lease(4)
$ i 147 $ i 126 
Distributors & resellers(5)
 i 254  i 223 
Customer direct i 201  i 216 
Total Sales$ i 602 $ i 565 
_____________
(1)Geographic area data is based upon the location of the subsidiary reporting the revenue.
(2)Includes revenues from maintenance agreements on sold equipment as well as revenues associated with service agreements sold through our channel partners as Xerox Partner Print Services (XPPS).
(3)Primarily includes revenues from our Managed Services offerings. Also includes revenues from embedded operating leases, which were not significant.
(4)Primarily reflects sales through bundled lease arrangements.
(5)Primarily reflects sales through our two-tier distribution channels.
 / 
Contract Assets and Liabilities: We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time. Our contract liabilities, which represent billings in excess of revenue recognized, are primarily related to advanced billings for maintenance and other services to be performed and were approximately $ i 126 and $ i 130 at March 31, 2021 and December 31, 2020, respectively. The majority of the balance at March 31, 2021 is expected to be amortized to revenue over approximately the next  i 30 months.
Contract Costs: Incremental direct costs of obtaining a contract primarily include sales commissions paid to sales people and agents in connection with the placement of equipment with associated post sale services arrangements. These costs are deferred and amortized on the straight-line basis over the estimated contract term, which is currently estimated to be approximately  i four years. We pay commensurate sales commissions upon customer renewals, therefore our amortization period is aligned to our initial contract term.
 i 
Incremental direct costs are as follows:
Three Months Ended
March 31,
20212020
Incremental direct costs of obtaining a contract$ i 13 $ i 15 
Amortization of incremental direct costs i 19  i 21 
 / 
Xerox 2021 Form 10-Q 13


The balance of deferred incremental direct costs net of accumulated amortization at March 31, 2021 and December 31, 2020 was $ i 140 and $ i 145, respectively. This amount is expected to be amortized over its estimated period of benefit, which we currently estimate to be approximately  i four years.
We may also incur costs associated with our services arrangements to generate or enhance resources and assets that will be used to satisfy our future performance obligations included in these arrangements. These costs are considered contract fulfillment costs and are amortized over the contractual service period of the arrangement to cost of services. In addition, we provide inducements to certain customers in various forms, including contractual credits, which are capitalized and amortized as a reduction of revenue over the term of the contract. As of March 31, 2021 and December 31, 2020 amounts deferred associated with contract fulfillment costs and inducements were $ i 17 and $ i 13, respectively. The related amortization was $ i 1 and $ i 1 for the three months ended March 31, 2021 and 2020, respectively.
Equipment and software used in the fulfillment of service arrangements and where the Company retains control are capitalized and depreciated over the shorter of their useful life or the term of the contract if an asset is contract specific.
Note 4 –  i  i Lessor / 
Revenue from sales-type leases is presented on a gross basis when the company enters into a lease to realize value from a product that it would otherwise sell in its ordinary course of business, whereas in transactions where the Company enters into a lease for the purpose of generating revenue by providing financing, the profit or loss, if any, is presented on a net basis. In addition, we have elected to account for sales tax and other similar taxes collected from a lessee as lessee costs and therefore we exclude these costs from contract consideration and variable consideration and present revenue net of these costs.
 i  i  i 
The components of lease income are as follows:
Three Months Ended
March 31,
Location in Statements of Income (Loss)20212020
Revenue from sales type leasesSales$ i 147 $ i 126 
Interest income on lease receivablesFinancing i 55  i 59 
Lease income - operating leasesServices, maintenance and rentals i 67  i 86 
Variable lease incomeServices, maintenance and rentals i 15  i 22 
Total Lease income$ i 284 $ i 293 
 / 
 / 
 / 

Profit at lease commencement on sales type leases was estimated to be $ i 56 and $ i 43 for the three months ended March 31, 2021 and 2020, respectively.
Xerox 2021 Form 10-Q 14


Note 5 –  i Supplementary Financial Information
Cash, Cash Equivalents and Restricted Cash
 i 
Cash, cash equivalents and restricted cash amounts were as follows:
March 31,
2021
December 31,
2020
Cash and cash equivalents$ i 2,379 $ i 2,625 
Restricted cash
    Litigation deposits in Brazil i 38  i 42 
    Escrow and cash collections related to secured borrowing arrangements(1)
 i 43  i 22 
    Other restricted cash i 1  i 2 
    Total Restricted cash i 82  i 66 
Cash, cash equivalents and restricted cash$ i 2,461 $ i 2,691 
_____________
(1)Represents collections on finance receivables pledged for secured borrowings that will be remitted to lenders in the following month.
 / 
Restricted cash primarily relates to cash collections on finance receivables that were pledged for secured borrowings as well as escrow cash deposits made in Brazil associated with ongoing litigation. As more fully discussed in Note 19 - Contingencies and Litigation, various litigation matters in Brazil require us to make cash deposits to escrow as a condition of continuing the litigation. Restricted cash amounts are classified in our Condensed Consolidated Balance Sheets based on when the cash will be contractually or judicially released.
 i 
Restricted cash was reported in the Condensed Consolidated Balance Sheets as follows:
March 31,
2021
December 31,
2020
Other current assets$ i 44 $ i 23 
Other long-term assets i 38  i 43 
Total Restricted cash$ i 82 $ i 66 
 / 

Supplemental Cash Flow Information
 i 
Summarized cash flow information is as follows:
Three Months Ended
March 31,
20212020
Provision for receivables$ i 11 $ i 74 
Provision for inventory i 9  i 6 
Provision for product warranty i 2  i 2 
Depreciation of buildings and equipment i 19  i 21 
Depreciation and obsolescence of equipment on operating leases i 42  i 51 
Amortization of internal use software i 10  i 11 
Amortization of acquired intangible assets(1)
 i 15  i 11 
Amortization of customer contract costs(2)
 i 20  i 22 
Cost of additions to land, buildings and equipment i 8  i 18 
Cost of additions to internal use software i 9  i 5 
Common stock dividends - Xerox Holdings Corporation i 50  i 54 
Preferred stock dividends - Xerox Holdings Corporation i 4  i 4 
Repurchases related to stock-based compensation - Xerox Holdings Corporation i 4  i 7 
_____________
(1)Amortization of acquired intangible assets of Xerox is $ i 14 for the three months ended March 31, 2021.
(2)Amortization of customer contract costs is reported in Decrease (increase) in other current and long-term assets in the Condensed Consolidated Statements of Cash Flows. Refer to Note 3 - Revenue - Contract Costs for additional information.
 / 
Xerox 2021 Form 10-Q 15


Note 6 –  i Accounts Receivable, Net
 i 
Accounts receivable, net were as follows:
March 31,
2021
December 31,
2020
Invoiced$ i 637 $ i 735 
Accrued(1)
 i 212  i 217 
Allowance for doubtful accounts( i 68)( i 69)
Accounts receivable, net$ i 781 $ i 883 
_____________
(1)Accrued receivables include amounts to be invoiced in the subsequent quarter for current services provided.
 / 
 i 
The allowance for doubtful accounts was as follows:
20212020
Balance at December 31st
$ i 69 $ i 55 
Provision i 4  i 8 
Charge-offs( i 5)( i 2)
Recoveries and other(1)
 i  ( i 1)
Balance at March 31st
$ i 68 $ i 60 
_____________
(1)Includes the impacts of foreign currency translation and adjustments to reserves necessary to reflect events of non-payment such as customer accommodations and contract terminations.
 / 

We perform ongoing credit evaluations of our customers and adjust credit limits based upon customer payment history and current creditworthiness. The allowance for uncollectible accounts receivable is determined based on an assessment of past collection experience as well as consideration of current and future economic conditions and changes in our customer collection trends. Based on that assessment the allowance for doubtful accounts as a percent of gross accounts receivable was  i 8.0% at March 31, 2021 and  i 7.2% at December 31, 2020. The allowance for doubtful accounts as a percent of gross accounts receivable remain at an elevated level as compared to historical levels primarily as a result of the macroeconomic and market disruption caused by COVID-19.
Accounts Receivable Sales Arrangements
Accounts receivable sales arrangements are utilized in the normal course of business as part of our cash and liquidity management. The accounts receivable sold are generally short-term trade receivables with payment due dates of less than 60 days. We have one facility in Europe that enables us to sell accounts receivable associated with our distributor network on an ongoing basis, without recourse. Under this arrangement, we sell our entire interest in the related accounts receivable for cash and no portion of the payment is held back or deferred by the purchaser.
Of the accounts receivable sold and derecognized from our balance sheet, $ i 93 and $ i 136 remained uncollected as of March 31, 2021 and December 31, 2020, respectively.
 i 
Accounts receivable sales activity was as follows:
 Three Months Ended
March 31,
 20212020
Accounts receivable sales(1)
$ i 107 $ i 53 
____________
(1)Losses on sales were not material. Customers may also enter into structured-payable arrangements that require us to sell our receivables from that customer to a third-party financial institution, which then makes payments to us to settle the customer's receivable. In these instances, we ensure the sale of the receivables are bankruptcy-remote and the payment made to us is without recourse. The activity associated with these arrangements is not reflected in this disclosure, as payments under these arrangements have not been material and these are customer directed arrangements.
 / 
Xerox 2021 Form 10-Q 16


Note 7 - Finance Receivables, Net
Finance receivables include sales-type leases and installment loans arising from the marketing of our equipment. These receivables are typically collateralized by a security interest in the underlying assets.
 i 
Finance receivables, net were as follows:
 March 31,
2021
December 31,
2020
Gross receivables$ i 3,596 $ i 3,691 
Unearned income( i 384)( i 393)
Subtotal i 3,212  i 3,298 
Residual values i   i  
Allowance for doubtful accounts( i 135)( i 133)
Finance receivables, net i 3,077  i 3,165 
Less: Billed portion of finance receivables, net i 92  i 99 
Less: Current portion of finance receivables not billed, net i 1,065  i 1,082 
Finance receivables due after one year, net$ i 1,920 $ i 1,984 
 / 
Finance Receivables – Allowance for Credit Losses and Credit Quality
Our finance receivable portfolios are primarily in the U.S., Canada and EMEA. We generally establish customer credit limits and estimate the allowance for credit losses on a country or geographic basis. Customer credit limits are based upon an initial evaluation of the customer's credit quality and we adjust that limit accordingly based upon ongoing credit assessments of the customer, including payment history and changes in credit quality.
The allowance for credit losses is determined principally based on an assessment of origination year and past collection experience as well as consideration of current and future economic conditions and changes in our customer collection trends. Based on that assessment the allowance for doubtful credit losses as a percentage of gross finance receivables (net of unearned income) was  i 4.2% at March 31, 2021 and  i 4.0% at December 31, 2020. In determining the level of reserve required we had to critically assess current and forecasted economic conditions in light of the COVID-19 pandemic to ensure we objectively included those expected impacts in the determination of our reserve. Our assessment also included a review of current portfolio credit metrics and the level of write-offs incurred over the past year of the COVID-19 pandemic.
The allowance for doubtful accounts and provision for credit losses represents an estimate of the losses expected to be incurred from the Company's finance receivable portfolio. The level of the allowance is determined on a collective basis by applying projected loss rates to our different portfolios by country, which represent our portfolio segments. This is the level at which we develop and document our methodology to determine the allowance for credit losses. This projected loss rates are primarily based upon historical loss experience adjusted for judgments about the probable effects of relevant observable data including current and future economic conditions as well as delinquency trends, resolution rates, the aging of receivables, credit quality indicators and the financial health of specific customer classes or groups.
The allowance for doubtful finance receivables is inherently more difficult to estimate than the allowance for trade accounts receivable because the underlying lease portfolio has an average maturity, at any time, of approximately two to  i three years and contains past due billed amounts, as well as unbilled amounts. We consider all available information in our quarterly assessments of the adequacy of the allowance for doubtful accounts. We believe our estimates, including any qualitative adjustments, are reasonable and have considered all reasonably available information about past events, current conditions, and reasonable and supportable forecasts of future events and economic conditions. The identification of account-specific exposure is not a significant factor in establishing the allowance for doubtful finance receivables. Our policy and methodology used to establish our allowance for doubtful accounts has been consistently applied over all periods presented.
Since our allowance for doubtful finance receivables is effectively determined by geography, the risk characteristics in our finance receivable portfolio segments will generally be consistent with the risk factors associated with the economies of the countries/regions included in those geographies. Since EMEA is comprised of various countries and regional economies, the risk profile within that portfolio segment is somewhat more diversified due to the varying economic conditions among and within the countries.
The first quarter 2020 reflected an incremental $ i 60 provision to cover estimated write-offs on our finance receivable portfolio from the economic disruption caused by the COVID-19 pandemic. Subsequent to the first quarter of 2020 provision and through the first quarter of 2021, actual write-offs incurred to date have lagged expectations but
Xerox 2021 Form 10-Q 17


remain in line with our original projections over the life of the lease portfolio and consistent with future expectations regarding our estimated impacts from the COVID-19 pandemic. Accordingly, our total reserve as a percent of receivables has remained fairly consistent subsequent to the first quarter 2020 charge at around  i 4%.
 i 
The allowance for doubtful accounts as well as the related investment in finance receivables were as follows:
United StatesCanada
EMEA(1)
Total
$ i 77 $ i 15 $ i 41 $ i 133 
Provision i 2  i 1  i 3  i 6 
Charge-offs( i 2) i  ( i 1)( i 3)
Recoveries and other(2)
 i 1  i  ( i 2)( i 1)
Balance at March 31, 2021$ i 78 $ i 16 $ i 41 $ i 135 
Finance receivables as of March 31, 2021 collectively evaluated for impairment (3)
$ i 1,806 $ i 288 $ i 1,118 $ i 3,212 
$ i 59 $ i 10 $ i 20 $ i 89 
Provision i 35  i 6  i 25  i 66 
Charge-offs( i 3)( i 1)( i 4)( i 8)
Recoveries and other(2)
 i   i  ( i 1)( i 1)
Balance at March 31, 2020$ i 91 $ i 15 $ i 40 $ i 146 
Finance receivables as of March 31, 2020 collectively evaluated for impairment(3)
$ i 1,866 $ i 289 $ i 1,132 $ i 3,287 
_____________
(1)Includes developing market countries.
(2)Includes the impacts of foreign currency translation and adjustments to reserves necessary to reflect events of non-payment such as customer accommodations and contract terminations.
 / 
(3)Total Finance receivables exclude the allowance for credit losses of $ i 135 and $ i 146 at March 31, 2021 and 2020, respectively.
In the U.S., customers are further evaluated by class based on the type of lease origination. The primary categories are direct, which primarily includes leases originated directly with end customers through bundled lease arrangements, and indirect, which primarily includes leases originated through our XBS sales channel that utilizes a combination of internal and third party leasing in its lease arrangements with end customers. Indirect also includes lease financing to end-user customers who purchased equipment we sold to distributors or resellers.
We evaluate our customers based on the following credit quality indicators:
Low Credit Risk: This rating includes accounts with excellent to good business credit, asset quality and capacity to meet financial obligations. These customers are less susceptible to adverse effects due to shifts in economic conditions or changes in circumstance. The rating generally equates to a Standard & Poor's (S&P) rating of BBB- or better. Loss rates in this category in the normal course are generally less than  i 1%.
Average Credit Risk: This rating includes accounts with average credit risk that are more susceptible to loss in the event of adverse business or economic conditions. This rating generally equates to a BB S&P rating. Although we experience higher loss rates associated with this customer class, we believe the risk is somewhat mitigated by the fact that our leases are fairly well dispersed across a large and diverse customer base. In addition, the higher loss rates are largely offset by the higher rates of return we obtain with such leases. Loss rates in this category in the normal course are generally in the range of  i 2% to  i 5%.
High Credit Risk: This rating includes accounts that have marginal credit risk such that the customer’s ability to make repayment is impaired or may likely become impaired. We use numerous strategies to mitigate risk including higher rates of interest, prepayments, personal guarantees, etc. Accounts in this category include customers who were downgraded during the term of the lease from low and average credit risk evaluation when the lease was originated. Accordingly, there is a distinct possibility for a loss of principal and interest or customer default. The loss rates in this category in the normal course are generally in the range of  i 7% to  i 10%.
Credit quality indicators are updated at least annually, or more frequently to the extent required by economic conditions, and the credit quality of any given customer can change during the life of the portfolio.
Xerox 2021 Form 10-Q 18


 i 
Details about our finance receivables portfolio based on geography, origination year and credit quality indicators are as follows:
 March 31, 2021
 20212020201920182017PriorTotal
Finance
Receivables
United States (Direct):
Low Credit Risk$ i 46 $ i 154 $ i 134 $ i 111 $ i 56 $ i 21 $ i 522 
Average Credit Risk i 17  i 53  i 89  i 43  i 20  i 6  i 228 
High Credit Risk i 18  i 87  i 39  i 24  i 12  i 5  i 185 
Total $ i 81 $ i 294 $ i 262 $ i 178 $ i 88 $ i 32 $ i 935 
United States (Indirect):
Low Credit Risk$ i 57 $ i 194 $ i 140 $ i 69 $ i 26 $ i 4 $ i 490 
Average Credit Risk i 42  i 110  i 99  i 56  i 24  i 5  i 336 
High Credit Risk i 9  i 16  i 8  i 8  i 3  i 1  i 45 
Total$ i 108 $ i 320 $ i 247 $ i 133 $ i 53 $ i 10 $ i 871 
Canada
Low Credit Risk$ i 11 $ i 36 $ i 31 $ i 21 $ i 7 $ i 3 $ i 109 
Average Credit Risk i 10  i 44  i 36  i 23  i 15  i 4  i 132 
High Credit Risk i 3  i 16  i 10  i 9  i 7  i 2  i 47 
Total$ i 24 $ i 96 $ i 77 $ i 53 $ i 29 $ i 9 $ i 288 
EMEA(1)
Low Credit Risk$ i 65 $ i 176 $ i 156 $ i 109 $ i 46 $ i 14 $ i 566 
Average Credit Risk i 52  i 153  i 138  i 89  i 38  i 12  i 482 
High Credit Risk i 7  i 19  i 21  i 12  i 8  i 3  i 70 
Total$ i 124 $ i 348 $ i 315 $ i 210 $ i 92 $ i 29 $ i 1,118 
Total Finance Receivables
Low Credit Risk$ i 179 $ i 560 $ i 461 $ i 310 $ i 135 $ i 42 $ i 1,687 
Average Credit Risk i 121  i 360  i 362  i 211  i 97  i 27  i 1,178 
High Credit Risk i 37  i 138  i 78  i 53  i 30  i 11  i 347 
Total$ i 337 $ i 1,058 $ i 901 $ i 574 $ i 262 $ i 80 $ i 3,212 
 / 
Xerox 2021 Form 10-Q 19




 December 31, 2020
 20202019201820172016PriorTotal
Finance
Receivables
United States (Direct):
Low Credit Risk$ i 164 $ i 151 $ i 128 $ i 71 $ i 32 $ i 4 $ i 550 
Average Credit Risk i 54  i 95  i 52  i 26  i 8  i 2  i 237 
High Credit Risk i 90  i 42  i 27  i 13  i 5  i 3  i 180 
Total $ i 308 $ i 288 $ i 207 $ i 110 $ i 45 $ i 9 $ i 967 
United States (Indirect):
Low Credit Risk$ i 193 $ i 140 $ i 79 $ i 33 $ i 7 $ i  $ i 452 
Average Credit Risk i 129  i 124  i 71  i 31  i 8  i   i 363 
High Credit Risk i 19  i 9  i 9  i 3  i 1  i   i 41 
Total$ i 341 $ i 273 $ i 159 $ i 67 $ i 16 $ i  $ i 856 
Canada
Low Credit Risk$ i 37 $ i 34 $ i 24 $ i 10 $ i 5 $ i 1 $ i 111 
Average Credit Risk i 46  i 39  i 26  i 17  i 6  i 1  i 135 
High Credit Risk i 18  i 10  i 10  i 10  i 3  i   i 51 
Total$ i 101 $ i 83 $ i 60 $ i 37 $ i 14 $ i 2 $ i 297 
EMEA(1)
Low Credit Risk$ i 197 $ i 177 $ i 131 $ i 62 $ i 20 $ i 4 $ i 591 
Average Credit Risk i 170  i 160  i 108  i 51  i 17  i 4  i 510 
High Credit Risk i 23  i 24  i 15  i 10  i 4  i 1  i 77 
Total$ i 390 $ i 361 $ i 254 $ i 123 $ i 41 $ i 9 $ i 1,178 
Total Finance Receivables
Low Credit Risk$ i 591 $ i 502 $ i 362 $ i 176 $ i 64 $ i 9 $ i 1,704 
Average Credit Risk i 399  i 418  i 257  i 125  i 39  i 7  i 1,245 
High Credit Risk i 150  i 85  i 61  i 36  i 13  i 4  i 349 
Total$ i 1,140 $ i 1,005 $ i 680 $ i 337 $ i 116 $ i 20 $ i 3,298 
_____________
(1)Includes developing market countries.

Xerox 2021 Form 10-Q 20


The aging of our receivables portfolio is based upon the number of days an invoice is past due. Receivables that are more than 90 days past due are considered delinquent. Receivable losses are charged against the allowance when management believes the uncollectibility of the receivable is confirmed and is generally based on individual credit evaluations, results of collection efforts and specific circumstances of the customer. Subsequent recoveries, if any, are credited to the allowance.
We generally continue to maintain equipment on lease and provide services to customers that have invoices for finance receivables that are 90 days or more past due and, as a result of the bundled nature of billings, we also continue to accrue interest on those receivables. However, interest revenue for such billings is only recognized if collectability is deemed reasonably assured.
 i 
The aging of our billed finance receivables is as follows:
 March 31, 2021
 Current
31-90
Days
Past Due
>90 Days
Past Due
Total BilledUnbilled
Total
Finance
Receivables
>90 Days
and
Accruing
Direct $ i 30 $ i 7 $ i 8 $ i 45 $ i 890 $ i 935 $ i 70 
Indirect i 18  i 4  i 3  i 25  i 846  i 871  i  
Total United States i 48  i 11  i 11  i 70  i 1,736  i 1,806  i 70 
Canada i 6  i 2  i 1  i 9  i 279  i 288  i 13 
EMEA(1)
 i 12  i 3  i 2  i 17  i 1,101  i 1,118  i 17 
Total$ i 66 $ i 16 $ i 14 $ i 96 $ i 3,116 $ i 3,212 $ i 100 
 December 31, 2020
 Current
31-90
Days
Past Due
>90 Days
Past Due
Total BilledUnbilled
Total
Finance
Receivables
>90 Days
and
Accruing
Direct$ i 33 $ i 6 $ i 9 $ i 48 $ i 919 $ i 967 $ i 74 
Indirect i 21  i 4  i 3  i 28  i 828  i 856  i  
Total United States i 54  i 10  i 12  i 76  i 1,747  i 1,823  i 74 
Canada i 8  i 2  i   i 10  i 287  i 297  i 12 
EMEA(1)
 i 12  i 3  i 2  i 17  i 1,161  i 1,178  i 23 
Total$ i 74 $ i 15 $ i 14 $ i 103 $ i 3,195 $ i 3,298 $ i 109 
_____________
(1)Includes developing market countries
 / 
Secured Borrowings and Collateral
In July 2020, we sold $ i 355 of U.S. based finance receivables to a consolidated special purpose entity (SPE), which funded the purchase through a secured loan agreement with a financial institution. As of March 31, 2021 the SPE holds $ i 248 of total Finance receivables, net, which are included in our Condensed Consolidated Balance Sheet as collateral for the secured loan agreement.
In December 2020, we sold $ i 610 of U.S. based finance receivables to a consolidated SPE, which funded the purchase through a secured loan agreement with a financial institution. As of March 31, 2021 the SPE holds $ i 543 of total Finance receivables, net, which are included in our Condensed Consolidated Balance Sheet as collateral for the secured loan agreement.
Refer to Note 11 - Debt, for additional information related to this arrangement including the related secured loan agreement.
Xerox 2021 Form 10-Q 21


Note 8 –  i Inventories and Equipment on Operating Leases, Net
 i 
The following is a summary of Inventories by major category:
March 31,
2021
December 31,
2020
Finished goods$ i 697 $ i 707 
Work-in-process i 48  i 43 
Raw materials i 96  i 93 
Total Inventories$ i 841 $ i 843 
 / 
The transfer of equipment from our inventories to equipment subject to an operating lease is presented in our Condensed Consolidated Statements of Cash Flows in the operating activities section. Equipment on operating leases and similar arrangements consists of our equipment rented to customers and depreciated to estimated salvage value at the end of the lease term.
 i 
Equipment on operating leases and the related accumulated depreciation were as follows:
 March 31,
2021
December 31,
2020
Equipment on operating leases$ i 1,332 $ i 1,376 
Accumulated depreciation( i 1,055)( i 1,080)
Equipment on operating leases, net$ i 277 $ i 296 
 / 
Total contingent rentals on operating leases, consisting principally of usage charges in excess of minimum contracted amounts, were $ i 15 and $ i 22 for the three months ended March 31, 2021 and 2020, respectively.
Xerox 2021 Form 10-Q 22


Note 9 –  i Lessee
 i Operating Leases
We have operating leases for real estate and vehicles in our domestic and international operations and for certain equipment in our domestic operations. Additionally, we have identified embedded operating leases within certain supply chain contracts for warehouses, primarily within our domestic operations. Our leases have remaining terms of up to  i twelve years and a variety of renewal and/or termination options.
 i 
The components of lease expense are as follows:
Three Months Ended
March 31,
20212020
Operating lease expense$ i 27 $ i 28 
Short-term lease expense i 5  i 5 
Variable lease expense(1)
 i 12  i 12 
Sublease income( i 1) i  
Total Lease expense$ i 43 $ i 45 
_____________
 / 
(1)Variable lease expense is related to our leased real estate for offices and warehouses and primarily includes labor and operational costs as well as taxes and insurance.
As of March 31, 2021, we have  i one additional real estate operating lease that has not yet commenced. This operating lease has an obligation and corresponding right-of-use (ROU) asset of $ i  i 8 /  and commenced in April 2021 with a lease term of approximately  i 6 years and a  i one-time option to terminate the lease after  i 3 years.
 i 
Operating lease ROU assets, net and operating lease liabilities were reported in the Condensed Consolidated Balance Sheets as follows:
March 31,
2021
December 31,
2020
Other long-term assets$ i 287 $ i 310 
Accrued expenses and other current liabilities$ i 79 $ i 83 
Other long-term liabilities i 231  i 250 
Total Operating lease liabilities$ i 310 $ i 333 
 / 

Xerox 2021 Form 10-Q 23


Note 10 –  i Restructuring Programs
We engage in restructuring actions through Project Own It as well as other transformation efforts in order to reduce our cost structure and realign it to the changing nature of our business. As part of our efforts to reduce costs, our restructuring actions may also include the off-shoring or outsourcing of certain operations, services and other functions, as well as reducing our real estate footprint.
During the three months ended March 31, 2021, we recorded net restructuring and asset impairment charges of $ i 21, which included $ i 14 of severance costs related to headcount reductions of approximately  i 350 employees worldwide, $ i 1 of other contractual termination costs and $ i 10 of asset impairment charges. These costs were partially offset by $ i 4 of net reversals, primarily resulting from changes in estimated reserves from prior period initiatives.
 i 
Information related to restructuring program activity is outlined below:
Severance and
Related Costs
Other Contractual Termination Costs(2)
Asset Impairments(3)
Total
Balance at December 31, 2020$ i 78 $ i 4 $ i  $ i 82 
Provision i 14  i 1  i 10  i 25 
Reversals( i 4) i   i  ( i 4)
Net current period charges(1)
 i 10  i 1  i 10  i 21 
Charges against reserve and currency( i 29)( i 1)( i 10)( i 40)
Balance at March 31, 2021$ i 59 $ i 4 $ i  $ i 63 
______________
(1)Represents net amount recognized within the Condensed Consolidated Statements of Income (Loss) for the period shown for restructuring and asset impairment charges.
(2)Primarily includes additional costs incurred upon the exit from our facilities including decommissioning costs and associated contractual termination costs.
(3)Primarily relates to the exit and abandonment of leased and owned facilities. The charge includes the accelerated write-off of $ i 1 for leased ROU assets and $ i 9 for owned assets upon exit from the facilities, net of any potential sublease income and other recoveries, including potential sales, in the first quarter of 2021.
 / 
 i 
The following table summarizes the reconciliation to the Condensed Consolidated Statements of Cash Flows:
 Three Months Ended
March 31,
 20212020
Charges against reserve and currency$( i 40)$( i 35)
Effects of foreign currency and other non-cash items i 13  i  
Restructuring cash payments$( i 27)$( i 35)
 / 
 i 
In connection with our restructuring programs, we also incurred certain related costs as follows:
Three Months Ended
March 31,
20212020
Retention related severance/bonuses(1)
$( i 4)$ i 7 
Contractual severance costs i   i 4 
Consulting and other costs(2)
 i   i 1 
Total$( i 4)$ i 12 
_____________
(1)Includes retention related severance and bonuses for employees expected to continue working beyond their minimum notification period before termination. The credit of $ i 4 in the first quarter 2021 reflects a change in estimate.
(2)Represents professional support services associated with our business transformation initiatives.
 / 

Cash paid for restructuring related costs were approximately $ i 3 and $ i 0 for the three months ended March 31, 2021 and 2020, respectively, while the reserve was $ i 13 and $ i 21 at March 31, 2021 and December 31, 2020. The balance at March 31, 2021 is expected to be paid over the next twelve months.
Xerox 2021 Form 10-Q 24


Note 11 –  i Debt
Xerox Holdings Corporation / Xerox Corporation Intercompany Loan
In August 2020, Xerox Holdings Corporation issued $ i 550 of  i 5.00% Senior Notes due August 2025 (the "2025 Senior Notes") at par and $ i 550 of  i 5.50% Senior Notes due August 2028 (the "2028 Senior Notes") at par resulting in aggregate net proceeds (after fees and expenses) of approximately $ i 1,089. On August 24, 2020, Xerox Holdings Corporation issued an additional $ i 200 of the 2025 Senior Notes at  i 100.75% of par and an additional $ i 200 of the 2028 Senior Notes at  i 102.50% of par resulting in additional aggregate net proceeds (after premium, fees and expenses) of approximately $ i 405 for total aggregate net proceeds from both issuances of approximately $ i 1,494. In 2020, the net debt proceeds were contributed by Xerox Holdings Corporation to Xerox Corporation and recorded as Additional paid-in capital by Xerox Corporation.
In February 2021, Xerox Holdings Corporation and Xerox Corporation entered into an Intercompany Loan agreement for the net proceeds of $ i 1,494 contributed by Xerox Holdings Corporation to Xerox Corporation in 2020. The intercompany loan, which did not involve the exchange of cash in the current period, resulted in the capitalization of the amount as Related Party Debt for Xerox Corporation as of March 31, 2021. The amount was originally recorded as Additional paid-in capital in 2020 when the cash was contributed by Xerox Holdings Corporation.
The intercompany loan was established to mirror the terms included in Xerox Holdings Corporation’s 2025 and 2028 Senior Notes, including interest rates and payment dates. The intercompany interest expense also includes a ratable amount to reimburse Xerox Holdings Corporation for its debt issuance costs and premium.
At March 31, 2021, the balance of the Intercompany Loan reported in Xerox Corporation’s Condensed Consolidated Balance Sheet was $ i 1,494, which is net of related debt issuance costs, and the intercompany interest payable was $ i 10. Xerox Corporation’s interest expense for the three months ended March 31, 2021 included $ i 20 of interest expense associated with this Intercompany Loan.
Secured Borrowings and Collateral
In July 2020, we entered into a secured loan agreement with a financial institution where we sold $ i 355 of U.S. based finance receivables and the rights to payments under operating leases with an equipment net book value of $ i 10 to a special purpose entity (SPE). The purchase by the SPE was funded through an amortizing secured loan to the SPE from the financial institution of $ i 340. The debt has a variable interest rate based on LIBOR plus a spread (current rate of  i 1.69% at March 31, 2021).
In December 2020, we entered into a second secured loan agreement with a financial institution where we sold $ i 610 of U.S. based finance receivables to an SPE. The purchase by the SPE was funded through an amortizing secured loan to the SPE from the financial institution of $ i 500. The debt has a variable interest rate based on the financial institution's cost of funds plus a spread (current rate of  i 1.73% at March 31, 2021).
 i 
Below are the assets and liabilities held by the consolidated SPEs, which are included in our Condensed Consolidated Balance Sheets. As a result of the above sales, the assets of the SPEs are not available to satisfy any of our other obligations. Conversely, the credit holders of these SPEs borrowings do not have legal recourse to the Company’s general credit or other assets.
March 31,
2021
December 31,
2020
Assets held by SPEs
Billed portion of finance receivables, net$ i 25 $ i 28 
Finance receivables, net i 326 i 350
Finance receivables due after one year, net i 440 i 510
Equipment on operating leases, net i 6 i 8
Restricted cash(1)
 i 43  i 22 
Total Assets$ i 840 $ i 918 
Liabilities held by SPEs
Current portion of long-term debt, net(2)
$ i 380 $ i 394 
Long term debt, net(2)
 i 290 i 370
Total Liabilities$ i 670 $ i 764 
_____________
(1)Restricted cash is included in Other current assets in our Condensed Consolidated Balance Sheet.
(2)Net of debt issuance costs of $ i 3.
 / 
Xerox 2021 Form 10-Q 25


Interest Expense and Income
 i 
Interest expense and income were as follows:
Three Months Ended
March 31,
20212020
Interest expense(1)(2)
$ i 52 $ i 51 
Interest income(3)
 i 56  i 67 
_____________
(1)Includes Cost of financing as well as non-financing interest expense that is included in Other expenses, net in the Condensed Consolidated Statements of Income (Loss).
(2)Interest expense for the three month ended March 31, 2021 for Xerox Corporation includes $ i 20 of intercompany interest expense for the Xerox Holdings Corporation / Xerox Corporation Intercompany Loan.
(3)Includes Financing revenue as well as other interest income that is included in Other expenses, net in the Condensed Consolidated Statements of Income (Loss).
 / 
Note 12 –  i Financial Instruments
Interest Rate Risk Management
We use interest rate swap and interest rate cap agreements to manage our interest rate exposure and to achieve a desired proportion of variable and fixed rate debt. These derivatives may be designated as fair value hedges or cash flow hedges depending on the nature of the risk being hedged. At March 31, 2021 there were no material interest rate derivative contracts outstanding.
Foreign Exchange Risk Management
We are a global company and we are exposed to foreign currency exchange rate fluctuations in the normal course of our business. As a part of our foreign exchange risk management strategy, we use derivative instruments, primarily forward contracts and purchased option contracts, to hedge the following foreign currency exposures, thereby reducing volatility of earnings or protecting fair values of assets and liabilities:
Foreign currency-denominated assets and liabilities
Forecasted purchases and sales in foreign currency
At March 31, 2021 and December 31, 2020, we had outstanding forward exchange and purchased option contracts with gross notional values of $ i 968 and $ i 1,161 respectively, with terms of less than 12 months. Approximately  i 78% of the contracts at March 31, 2021 mature within three months,  i 11% mature in three to six months and  i 11% in six to twelve months. The decrease in hedge position from December 31, 2020 is primarily for GBP and YEN exposures due to lower requirements. There has not been any material change in our hedging strategy.
Foreign Currency Cash Flow Hedges
We designate a portion of our foreign currency derivative contracts as cash flow hedges of our foreign currency-denominated inventory purchases, sales and expenses. The net (liability) asset fair value of these contracts were $( i 7) and $ i 2 as of March 31, 2021 and December 31, 2020, respectively.
Xerox 2021 Form 10-Q 26


Summary of Derivative Instruments Fair Value
 i 
The following table provides a summary of the fair value amounts of our derivative instruments:
Designation of DerivativesBalance Sheet LocationMarch 31,
2021
December 31,
2020
Derivatives Designated as Hedging Instruments
Foreign exchange contracts - forwardsOther current assets$ i 1 $ i 3 
Accrued expenses and other current liabilities( i 8)( i 2)
Foreign currency optionsOther current assets i   i 1 
Net designated derivative (liability) asset$( i 7)$ i 2 
Derivatives NOT Designated as Hedging Instruments
Foreign exchange contracts – forwardsOther current assets$ i 3 $ i 3 
Accrued expenses and other current liabilities( i 6)( i 3)
Net undesignated derivative liability$( i 3)$ i  
Summary of DerivativesTotal Derivative assets$ i 4 $ i 7 
Total Derivative liabilities( i 14)( i 5)
Net Derivative (liability) asset$( i 10)$ i 2 
 / 
Summary of Derivative Instruments Gains (Losses)
Derivative gains and (losses) affect the income statement based on whether such derivatives are designated as hedges of underlying exposures. The following is a summary of derivative gains (losses).
Designated Derivative Instruments Gains (Losses)
 i 
The following table provides a summary of gains (losses) on derivative instruments:
Three Months Ended
March 31,
Gain (Loss) on Derivative Instruments20212020
Fair Value Hedges - Interest Rate Contracts
Derivative loss recognized in interest expense$ i  $( i 1)
Hedged item gain recognized in interest expense i   i 1 
Cash Flow Hedges - Foreign Exchange Forward Contracts and Options
Derivative (loss) gain recognized in OCI (effective portion)$( i 10)$ i 7 
Derivative loss reclassified from AOCL to income - Cost of sales (effective portion)( i 1)( i 1)
 / 
During the three months ended March 31, 2021 and 2020,  i  i no /  amount of ineffectiveness was recorded in the Condensed Consolidated Statements of Income (Loss) for these designated cash flow hedges and all components of each derivative’s gain or (loss) were included in the assessment of hedge effectiveness. In addition,  i  i  i  i no /  /  /  amount was recorded for an underlying exposure that did not occur or was not expected to occur.
As of March 31, 2021, a net after-tax loss of $ i 5 was recorded in Accumulated other comprehensive loss associated with our cash flow hedging activity. The entire balance is expected to be reclassified into net income within the next 12 months, providing an offsetting economic impact against the underlying anticipated transactions.
Non-Designated Derivative Instruments Gains (Losses)
Non-designated derivative instruments are primarily instruments used to hedge foreign currency-denominated assets and liabilities. They are not designated as hedges since there is a natural offset for the remeasurement of the underlying foreign currency-denominated asset or liability.
 i 
The following table provides a summary of gains and (losses) on non-designated derivative instruments:
Derivatives NOT Designated as Hedging InstrumentsLocation of Derivative (Loss) GainThree Months Ended
March 31,
20212020
Foreign exchange contracts – forwardsOther expense – Currency (losses) gains, net$( i 18)$ i 14 
 / 
For the three months ended March 31, 2021 and 2020 currency losses, net were $ i 2 and $ i 2, respectively. Net currency gains and losses include the mark-to-market adjustments of the derivatives not designated as hedging instruments and the related cost of those derivatives as well as the remeasurement of foreign currency-denominated assets and liabilities and are included in Other expenses, net.
Xerox 2021 Form 10-Q 27


Note 13 –  i Fair Value of Financial Assets and Liabilities
 i 
The following table represents assets and liabilities measured at fair value on a recurring basis. The basis for the measurement at fair value in all cases is Level 2 – Significant Other Observable Inputs. 
March 31,
2021
December 31,
2020
Assets
Foreign exchange contracts - forwards$ i 4 $ i 6 
Foreign currency options i   i 1 
Deferred compensation plan investments in mutual funds i 17  i 18 
Total$ i 21 $ i 25 
Liabilities
Foreign exchange contracts - forwards$ i 14 $ i 5 
Deferred compensation plan liabilities i 17  i 17 
Total$ i 31 $ i 22 
 / 
We utilize the income approach to measure the fair value for our derivative assets and liabilities. The income approach uses pricing models that rely on market observable inputs such as yield curves, currency exchange rates and forward prices, and therefore are classified as Level 2.
Fair value for our deferred compensation plan investments in mutual funds is based on quoted market prices for those funds. Fair value for deferred compensation plan liabilities is based on the fair value of investments corresponding to employees’ investment selections.
Summary of Other Financial Assets and Liabilities
 i 
The estimated fair values of our other financial assets and liabilities were as follows:
 March 31, 2021December 31, 2020
 
Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Cash and cash equivalents$ i 2,379 $ i 2,379 $ i 2,625 $ i 2,625 
Accounts receivable, net i 781  i 781  i 883  i 883 
Short-term debt and current portion of long-term debt i 678  i 688  i 394  i 396 
Long-term Debt
Xerox Holdings Corporation i 1,494  i 1,558  i 1,493  i 1,596 
Xerox Corporation i 1,890  i 1,992  i 2,187  i 2,298 
Xerox - Other Subsidiaries(1)
 i 290  i 292  i 370  i 372 
Long-term debt$ i 3,674 $ i 3,842 $ i 4,050 $ i 4,266 
_____________
(1)Represents subsidiaries of Xerox Corporation
 / 
The fair value amounts for Cash and cash equivalents and Accounts receivable, net, approximate carrying amounts due to the short maturities of these instruments. The fair value of Short-term debt, including the current portion of long-term debt, and Long-term debt was estimated based on the current rates offered to us for debt of similar maturities (Level 2). The difference between the fair value and the carrying value represents the theoretical net premium or discount we would pay or receive to retire all debt at such date.
Xerox 2021 Form 10-Q 28


Note 14 –  i Employee Benefit Plans
 i 
The components of Net periodic benefit cost and other changes in plan assets and benefit obligations were as follows:
Three Months Ended March 31,
Pension Benefits
U.S. PlansNon-U.S. PlansRetiree Health
Components of Net Periodic Benefit Costs:202120202021202020212020
Service cost$ i  $ i 1 $ i 5 $ i 5 $ i 1 $ i 1 
Interest cost i 18  i 23  i 22  i 29  i 2  i 2 
Expected return on plan assets( i 28)( i 26)( i 52)( i 47) i   i  
Recognized net actuarial loss i 5  i 7  i 15  i 14  i   i  
Amortization of prior service credit i   i   i   i  ( i 17)( i 19)
Recognized settlement loss i 15  i 19  i   i   i   i  
Recognized curtailment gain i   i   i  ( i 1) i   i  
Defined benefit plans i 10  i 24 ( i 10) i  ( i 14)( i 16)
Defined contribution plans i   i 5  i 5  i 5 n/an/a
Net Periodic Benefit Cost (Credit) i 10  i 29 ( i 5) i 5 ( i 14)( i 16)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial (gain) loss(1)
( i 44) i 12  i 1  i   i   i  
Amortization of net actuarial loss( i 20)( i 26)( i 15)( i 14) i   i  
Amortization of prior service credit i   i   i   i   i 17  i 19 
Total Recognized in Other Comprehensive Income (Loss)(2)
( i 64)( i 14)( i 14)( i 14) i 17  i 19 
Total Recognized in Net Periodic Benefit (Credit) Cost and Other Comprehensive Income (Loss)$( i 54)$ i 15 $( i 19)$( i 9)$ i 3 $ i 3 
_____________
(1)The net actuarial (gain) loss for U.S. Plans primarily reflects the remeasurement of our primary U.S. pension plans as a result of the payment of periodic settlements.
(2)Amounts represent the pre-tax effect included within Other Comprehensive Income (Loss). Refer to Note 17 - Other Comprehensive Income (Loss) for related tax effects and the after-tax amounts.
 / 
Contributions
 i 
The following table summarizes cash contributions to our defined benefit pension plans and retiree health benefit plans.
Three Months Ended
March 31,
Year Ended December 31,
20212020
Estimated 2021
2020
U.S. plans$ i 6 $ i 6 $ i 25 $ i 35 
Non-U.S. plans i 29  i 27  i 105  i 104 
Total Pension$ i 35 $ i 33 $ i 130 $ i 139 
Retiree Health$ i 6 $ i 5 $ i 30 $ i 25 
 / 
There are  i no mandatory contributions required in 2021 for our U.S. tax-qualified defined benefit plans to meet the minimum funding requirements.
Defined Contribution Plans
In the first quarter 2021, the Company temporarily suspended and will not make its full year 2021 employer match/contribution for its U.S. based 401(k) saving plans for salaried employees. The suspension is expected to result in savings of approximately $ i 20 for the year ending December 31, 2021.
Xerox 2021 Form 10-Q 29


Note 15 –  i Shareholders’ Equity of Xerox Holdings
(shares in thousands)
 i 
The shareholders' equity information presented below reflects the consolidated activity of Xerox Holdings.

Common
Stock(1)
Additional
Paid-in
Capital
Treasury Stock
Retained
Earnings
AOCL(2)
Xerox Holdings
Shareholders’
Equity
Non-controlling
Interests
Total
Equity
Balance at December 31, 2020$ i 198 $ i 2,445 $ i  $ i 6,281 $( i 3,332)$ i 5,592 $ i 4 $ i 5,596 
Comprehensive income (loss), net— — —  i 39 ( i 3) i 36  i   i 36 
Cash dividends declared - common(3)
— — — ( i 49)— ( i 49)— ( i 49)
Cash dividends declared - preferred(4)
— — — ( i 4)— ( i 4)— ( i 4)
Stock option and incentive plans, net i 1  i 11 — — —  i 12 —  i 12 
Payments to acquire treasury stock, including fees— — ( i 162)— — ( i 162)— ( i 162)
Balance at March 31, 2021$ i 199 $ i 2,456 $( i 162)$ i 6,267 $( i 3,335)$ i 5,425 $ i 4 $ i 5,429 

Common
Stock(1)
Additional
Paid-in
Capital
Treasury Stock
Retained
Earnings
AOCL(2)
Xerox Holdings
Shareholders’
Equity
Non-
controlling
Interests
Total
Equity
Balance at December 31, 2019$ i 215 $ i 2,782 $( i 76)$ i 6,312 $( i 3,646)$ i 5,587 $ i 7 $ i 5,594 
Comprehensive loss, net— — — ( i 2)( i 138)( i 140) i  ( i 140)
Cash dividends declared - common(3)
— — — ( i 54)— ( i 54)— ( i 54)
Cash dividends declared - preferred(4)
— — — ( i 4)— ( i 4)— ( i 4)
Stock option and incentive plans, net—  i 4 — — —  i 4 —  i 4 
Cancellation of treasury stock( i 2)( i 74) i 76 — — — —  i  
Balance at March 31, 2020$ i 213 $ i 2,712 $ i  $ i 6,252 $( i 3,784)$ i 5,393 $ i 7 $ i 5,400 
_____________
(1)Common Stock has a par value of $ i 1 per share.
(2)Refer to Note 17 - Other Comprehensive Income (Loss) for the components of AOCL.
(3)Cash dividends declared on common stock for the three months ended March 31, 2021 and 2020 were $ i  i 0.25 /  per share, respectively.
(4)Cash dividends declared on preferred stock for the three months ended March 31, 2021 and 2020 were $ i  i 20.00 /  per share, respectively.
 / 
Treasury Stock
 i 
The following is a summary of the purchases of common stock during 2021:
SharesAmount
Balance at December 31, 2020 i  $ i  
Purchases(1)
 i 6,704  i 162 
Cancellations i   i  
Balance at March 31, 2021 i 6,704 $ i 162 
_____________
(1)Includes associated fees.
 / 
Xerox 2021 Form 10-Q 30


Note 16 –  i Shareholder's Equity of Xerox
 i 
The shareholder's equity information presented below reflects the consolidated activity of Xerox.
Additional
Paid-in
Capital
Retained
Earnings
AOCL(1)
Xerox
Shareholder's
Equity
Non-controlling
Interests
Total
Equity
Balance at December 31, 2020$ i 4,879 $ i 5,834 $( i 3,332)$ i 7,381 $ i 4 $ i 7,385 
Comprehensive income (loss), net—  i 41 ( i 3) i 38 —  i 38 
Dividends declared to parent— ( i 201)— ( i 201)— ( i 201)
Intercompany loan capitalization(2)
( i 1,494)— — ( i 1,494)— ( i 1,494)
Transfers to parent( i 34)— — ( i 34)— ( i 34)
Balance at March 31, 2021$ i 3,351 $ i 5,674 $( i 3,335)$ i 5,690 $ i 4 $ i 5,694 

Additional
Paid-in
Capital
Retained
Earnings
AOCL(1)
Xerox
Shareholder's
Equity
Non-controlling
Interests
Total
Equity
Balance at December 31, 2019$ i 3,266 $ i 6,247 $( i 3,646)$ i 5,867 $ i 7 $ i 5,874 
Comprehensive loss, net— ( i 2)( i 138)( i 140) i  ( i 140)
Dividends declared to parent— ( i 290)— ( i 290)— ( i 290)
Transfers from parent i 238 — —  i 238 —  i 238 
Balance at March 31, 2020$ i 3,504 $ i 5,955 $( i 3,784)$ i 5,675 $ i 7 $ i 5,682 
_____________
(1)Refer to Note 17 - Other Comprehensive Income (Loss) for the components of AOCL.
 / 
(2)Refer to Note 11- Debt for information regarding capitalization of balance to Intercompany Loan with Xerox Holdings Corporation.
Xerox 2021 Form 10-Q 31


Note 17 -  i Other Comprehensive Income (Loss)
 i 
Other Comprehensive Income (Loss) is comprised of the following:
Three Months Ended
March 31,
20212020
Pre-taxNet of TaxPre-taxNet of Tax
Translation Adjustments Losses$( i 52)$( i 51)$( i 204)$( i 197)
Unrealized (Losses) Gains
Changes in fair value of cash flow hedges (losses) gains( i 10)( i 8) i 7  i 4 
Changes in cash flow hedges reclassed to earnings(1)
 i 1  i 1  i 1  i 1 
Net Unrealized (Losses) Gains ( i 9)( i 7) i 8  i 5 
Defined Benefit Plans Gains (Losses)
Net actuarial/prior service gains (losses) i 43  i 32 ( i 12)( i 9)
Prior service amortization(2)
( i 17)( i 12)( i 19)( i 14)
Actuarial loss amortization/settlement(2)
 i 35  i 26  i 40  i 30 
Other gains(3)
 i 9  i 9  i 47  i 47 
Changes in Defined Benefit Plans Gains i 70  i 55  i 56  i 54 
Other Comprehensive Income (Loss) Attributable to Xerox Holdings/Xerox$ i 9 $( i 3)$( i 140)$( i 138)
____________
(1)Reclassified to Cost of sales - refer to Note 12 - Financial Instruments for additional information regarding our cash flow hedges.
(2)Reclassified to Total Net Periodic Benefit Cost - refer to Note 14 - Employee Benefit Plans for additional information.
 / 
(3)Primarily represents currency impact on cumulative amount of benefit plan net actuarial losses and prior service credits in AOCL.

Accumulated Other Comprehensive Loss (AOCL)
 i 
AOCL is comprised of the following:
March 31,
2021
December 31,
2020
Cumulative translation adjustments$( i 1,771)$( i 1,720)
Other unrealized (losses) gains, net( i 5) i 2 
Benefit plans net actuarial losses and prior service credits( i 1,559)( i 1,614)
Total Accumulated Other Comprehensive Loss Attributable to Xerox Holdings/Xerox$( i 3,335)$( i 3,332)
 / 

Xerox 2021 Form 10-Q 32


Note 18 –  i Earnings (Loss) per Share
(shares in thousands)
 i 
The following table sets forth the computation of basic and diluted earnings (loss) per share of Xerox Holdings Corporation's common stock:
 Three Months Ended
March 31,
 20212020
Basic Earnings (Loss) per Share
Net Income (Loss) Attributable to Xerox Holdings$ i 39 $( i 2)
Accrued dividends on preferred stock( i 4)( i 4)
Adjusted Net income (loss) available to common shareholders$ i 35 $( i 6)
Weighted average common shares outstanding i 195,985  i 212,750 
Basic Earnings (Loss) per Share$ i 0.18 $( i 0.03)
Diluted Earnings (Loss) per Share
Net Income (Loss) Attributable to Xerox Holdings$ i 39 $( i 2)
Accrued dividends on preferred stock( i 4)( i 4)
Adjusted Net income (loss) available to common shareholders$ i 35 $( i 6)
Weighted average common shares outstanding i 195,985  i 212,750 
Common shares issuable with respect to:
Stock options i   i  
Restricted stock and performance shares i 2,181  i  
Convertible preferred stock i   i  
Adjusted weighted average common shares outstanding i 198,166  i 212,750 
Diluted Earnings (Loss) per Share$ i 0.18 $( i 0.03)
The following securities were not included in the computation of diluted earnings per share as they were either contingently issuable shares or shares that if included would have been anti-dilutive:
Stock options i 693  i 849 
Restricted stock and performance shares i 5,327  i 6,478 
Convertible preferred stock i 6,742  i 6,742 
Total Anti-Dilutive Securities i 12,762  i 14,069 
Dividends per Common Share$ i 0.25 $ i 0.25 
 / 
 
Xerox 2021 Form 10-Q 33


Note 19 –  i Contingencies and Litigation
Legal Matters
We are involved in a variety of claims, lawsuits, investigations and proceedings concerning: securities law; governmental entity contracting; servicing and procurement law; intellectual property law; environmental law; employment law; the Employee Retirement Income Security Act (ERISA); and other laws and regulations. We determine whether an estimated loss from a contingency should be accrued by assessing whether a loss is deemed probable and can be reasonably estimated. We assess our potential liability by analyzing our litigation and regulatory matters using available information. We develop our views on estimated losses in consultation with outside counsel handling our defense in these matters, which involves an analysis of potential results, assuming a combination of litigation and settlement strategies. Should developments in any of these matters cause a change in our determination as to an unfavorable outcome and result in the need to recognize a material accrual, or should any of these matters result in a final adverse judgment or be settled for significant amounts, they could have a material adverse effect on our results of operations, cash flows and financial position in the period or periods in which such change in determination, judgment or settlement occurs.
Brazil Contingencies
Our Brazilian operations have received or been the subject of numerous governmental assessments related to indirect and other taxes. The tax matters principally relate to claims for taxes on the internal transfer of inventory, municipal service taxes on rentals and gross revenue taxes. We are disputing these tax matters and intend to vigorously defend our positions. Based on the opinion of legal counsel and current reserves for those matters deemed probable of loss, we do not believe that the ultimate resolution of these matters will materially impact our results of operations, financial position or cash flows.  i Below is a summary of our Brazilian tax contingencies:
March 31,
2021
December 31,
2020
Tax contingency - unreserved$ i 335 $ i 355 
Escrow cash deposits i 35  i 39 
Surety bonds i 96  i 112 
Letters of credit i 72  i 78 
Liens on Brazilian assets i   i  
The decrease in the unreserved portion of the tax contingency, inclusive of any related interest, was primarily related to currency, partially offset by interest. With respect to the unreserved tax contingency, the majority has been assessed by management as being remote as to the likelihood of ultimately resulting in a loss to the Company. In connection with the above proceedings, customary local regulations may require us to make escrow cash deposits or post other security of up to half of the total amount in dispute, as well as, additional surety bonds and letters of credit, which include associated indexation. Generally, any escrowed amounts would be refundable and any liens on assets would be removed to the extent the matters are resolved in our favor. We are also involved in certain disputes with contract and former employees. Exposures related to labor matters are not material to the financial statements as of March 31, 2021 and December 31, 2020. We routinely assess all these matters as to the probability of ultimately incurring a liability against our Brazilian operations and record our best estimate of the ultimate loss in situations where we assess the likelihood of an ultimate loss as probable.
Litigation Against the Company
Pending Litigation Relating to the Fuji Transaction:
1.Ribbe v. Jacobson, et al.:
On April 11, 2019, Carmen Ribbe filed a putative derivative and class action stockholder complaint in the Supreme Court of the State of New York for New York County, naming as defendants Xerox, current Board members Joseph J. Echevarria, Cheryl Gordon Krongard, Keith Cozza, Giovanni G. Visentin, Jonathan Christodoro, Nicholas Graziano, and A. Scott Letier, and former Board members Jeffrey Jacobson, William Curt Hunter, Robert J. Keegan, Charles Prince, Ann N. Reese, Stephen H. Rusckowski, Gregory Q. Brown, and Sara Martinez Tucker. Plaintiff previously filed a putative shareholder derivative lawsuit on May 24, 2018 against certain of these defendants, as well as others, in the same court; that lawsuit was dismissed without prejudice on December 6, 2018 ("Ribbe I"). The new complaint included putative derivative claims on behalf of Xerox for breach of fiduciary duty against the then members of the Xerox Board who approved Xerox’s entry into agreements to settle shareholder actions filed in 2018 in the same court against Xerox, its then directors, and FUJIFILM Holdings Corporation (“Fujifilm”) in connection with a proposed transaction announced in January 2018 to combine Xerox and Fuji Xerox (the “Fuji
Xerox 2021 Form 10-Q 34


Transaction”), including a consolidated putative class action, In re Xerox Corporation Consolidated Shareholder Litigation (“XCCSL”), and actions filed by Darwin Deason, Deason v. Fujifilm Holdings Corp., et al. and Deason v. Xerox Corporation, et al., against the same defendants as well as, in the first Deason action, former Xerox Chief Executive Officer Ursula M. Burns (the "Fuji Transaction Shareholder Lawsuits"). Plaintiff alleged that the settlements ceded control of the Board and the Company to Darwin Deason and Carl C. Icahn without a vote by, or compensation to, other Xerox stockholders; improperly provided certain benefits and releases to the resigning and continuing directors; and subjected Xerox to potential breach of contract damages in an action by Fuji relating to Xerox’s termination of the proposed Fuji Transaction. Plaintiff also alleged that the current Board members breached their fiduciary duties by allegedly rejecting plaintiff’s January 14, 2019 shareholder demand on the Board to remedy harms arising from entry into the Deason and XCCSL settlements. The new complaint further included direct claims for breach of fiduciary duty on behalf of a putative class of current Xerox stockholders other than Mr. Deason, Mr. Icahn, and their affiliated entities (the “Ribbe Class”) against the defendants for causing Xerox to enter into the Deason and XCCSL settlements, which plaintiff alleged perpetuated control of Xerox by Mr. Icahn and Mr. Deason and denied the voting franchise of Xerox shareholders. Among other things, plaintiff sought damages in an unspecified amount for the alleged fiduciary breaches in favor of Xerox against defendants jointly and severally; rescission or reformation of the Deason and XCCSL settlements; restitution of funds paid to the resigning directors under the Deason settlement; an injunction against defendants’ engaging in the alleged wrongful practices and equitable relief affording the putative Ribbe Class the ability to determine the composition of the Board; costs and attorneys’ fees; and other further relief as the Court may deem proper.
Defendants accepted service of the complaint as of May 16, 2019. On June 4, 2019, the Court entered an order setting a briefing schedule for defendants’ motions to dismiss the complaint. On July 12, 2019, plaintiff filed a motion to preclude defendants from referencing in their motions to dismiss the formation of, or work by, the committee of the Board established to investigate plaintiff’s shareholder demand. On July 18, 2019, the Court denied plaintiff’s motion and adjourned sine die the deadline by which defendants must file any motions to dismiss the complaint.
On January 6, 2020, plaintiff filed his first amended complaint (“FAC”). The FAC includes many of plaintiff’s original allegations regarding the 2018 shareholder litigation and settlements, as well as additional allegations, including, among others, that the members of the Special Committee of the Board that investigated plaintiff’s demand lacked independence and wrongfully refused to pursue the claims in the demand; allegations that an agreement announced in November 2019 for, among other things, the sale by Xerox of its interest in Fuji Xerox to Fujifilm and dismissal of Fujifilm’s breach of contract lawsuit against Xerox (the “FX Sale Transaction”), was unfavorable to Xerox; and allegations about a potential acquisition by Xerox of HP similar to those in the Miami Firefighters derivative action described below. In addition to the claims in the April 11, 2019 complaint, the FAC adds as defendants Carl C. Icahn, Icahn Capital LP, and High River Limited Partnership (the “Icahn defendants”) and asserts claims against those defendants and the Board similar to those in Miami Firefighters relating to the Icahn defendants’ purchases of HP stock allegedly with knowledge of material nonpublic information concerning Xerox’s potential acquisition of HP. In addition to the relief sought in Ribbe’s prior complaint, the FAC seeks relief similar to that sought in Miami Firefighters relating to the Icahn defendants’ alleged purchases of HP stock.
On January 21, 2020, plaintiff in the Miami Firefighters action filed a motion seeking to intervene in Ribbe and to have stayed, or alternatively, severed and consolidated with the Miami Firefighters action, any claims first filed in Miami Firefighters and later asserted by Ribbe. At a conference held on February 25, 2020, the Court denied the motion to intervene without prejudice. On March 6, 2020, plaintiff in the Miami Firefighters action renewed its motion. On July 23, 2020, after hearing oral argument, the Court issued an order denying the motion and setting certain case deadlines.
Discovery commenced. On August 7, 2020, Xerox, the director defendants, and the Icahn defendants filed separate motions to dismiss. On October 1, 2020, plaintiff filed a cross-motion seeking, among other relief, joinder of Xerox Holdings Corporation as a nominal defendant. Briefing on the motions to dismiss and plaintiff’s cross-motion was completed on October 16, 2020. On December 14, 2020, following oral argument, the Court issued a decision and order denying plaintiff’s cross-motion and granting defendants’ motions, dismissing the action in its entirety as to all defendants. Dismissal as to the Icahn defendants was conditioned on the filing of an affidavit, which the Icahn defendants filed on December 16, 2020, indicating whether defendant Icahn gained a profit or incurred a loss on purchases of HP stock during the relevant time period.
On January 13, 2021, plaintiff filed a notice of appeal of the December 14, 2020 dismissal order to the Appellate Division, First Department.
Xerox 2021 Form 10-Q 35


On April 7, 2021, plaintiff filed in the previously dismissed Ribbe I and XCCSL actions a motion seeking an award of attorneys’ fees of $ i 1.5 and a service award of $ i 10 thousand for benefits he allegedly obtained for Xerox and its stockholders.
Xerox will vigorously defend against this matter. At this time, it is premature to make any conclusion regarding the probability of incurring material losses in this litigation. Should developments cause a change in our determination as to an unfavorable outcome, or result in a final adverse judgment or settlement, there could be a material adverse effect on our results of operations, cash flows and financial position in the period in which such change in determination, judgment, or settlement occurs.
2.Miami Firefighters’ Relief & Pension Fund v. Icahn, et al.:
On December 13, 2019, alleged shareholder Miami Firefighters’ Relief & Pension Fund (“Miami Firefighters”) filed a purported derivative complaint in New York State Supreme Court, New York County on behalf of Xerox Holdings Corporation ("Xerox Holdings") (as nominal defendant) against Carl Icahn and his affiliated entities High River Limited Partnership and Icahn Capital LP (the "Icahn defendants"), Xerox Holdings, and all current Xerox Holdings directors (the "Directors"). Plaintiff made no demand on the Board before bringing the action, but instead alleges that doing so would be futile because the Directors lack independence due to alleged direct or indirect relationships with Icahn. Among other things, the complaint alleges that Icahn controls and dominates Xerox Holdings and therefore owes a fiduciary duty of loyalty to Xerox Holdings, which he breached by acquiring HP stock at a time when he knew that Xerox Holdings was considering an offer to acquire HP or had knowledge of the "obvious merits" of such potential acquisition, and that the Icahn defendants’ holdings of HP common stock have risen in market value by approximately $ i 128 since disclosure of the offer.  The complaint includes four causes of action:  breach of fiduciary duty of loyalty against the Icahn defendants; breach of contract against the Icahn defendants (for purchasing HP stock in violation of Icahn’s confidentiality agreement with Xerox Holdings); unjust enrichment against the Icahn defendants; and breach of fiduciary duty of loyalty against the Directors (for any consent to the Icahn defendants’ purchases of HP common stock while Xerox Holdings was considering acquiring HP).  The complaint seeks a judgment of breach of fiduciary duties against the Icahn defendants and the Directors; a declaration that Icahn breached his confidentiality agreement with Xerox Holdings; a constructive trust on Icahn Capital and High River's investments in HP securities; disgorgement to Xerox Holdings of profits Icahn Capital and High River earned from trading in HP stock; payment of unspecified damages by the Directors for breaching fiduciary duties; and attorneys' fees, costs, and other relief the Court deems just and proper. On January 15, 2020, the Court entered an order granting plaintiff’s unopposed motion to consolidate with Miami Firefighters a similar action filed on December 26, 2019 by alleged shareholder Steven J. Reynolds against the same parties in the same court, and designating Miami Firefighters’ counsel as lead counsel in the consolidated action. On January 21, 2020, plaintiff filed a motion seeking to intervene in Ribbe v. Jacobson, et al., described above, and to have stayed, or alternatively, severed and consolidated with this action, any claims first filed in this action and later asserted by Ribbe. At a conference held on February 25, 2020, the Court denied the motion to intervene without prejudice. On March 6, 2020, plaintiff in the Miami Firefighters action renewed its motion. On July 23, 2020, after hearing oral argument, the Court issued an order denying the motion and setting certain case deadlines.
Discovery has commenced. On August 10, 2020, the Xerox defendants and the Icahn defendants filed separate motions to dismiss. Briefing on the motions was completed on October 21, 2020. On December 14, 2020, following oral argument, the Court issued a decision and order granting defendants’ motions and dismissing the action in its entirety as to all defendants. Dismissal as to the Icahn defendants was conditioned on the filing of an affidavit, which the Icahn defendants filed on December 16, 2020, indicating whether defendant Icahn gained a profit or incurred a loss on purchases of HP stock during the relevant time period.
On December 23, 2020, plaintiff filed a motion seeking discovery related to the Icahn defendants’ losses resulting from their investment in HP. The motion was fully briefed on January 7, 2021. On January 15, 2021, the Court issued a decision and order denying the motion.
Also on January 15, 2021, plaintiff filed a notice of appeal of the December 14, 2020 dismissal order to the Appellate Division, First Department. On January 20, 2021, plaintiff filed a notice of appeal of the January 15, 2021 order denying its motion for discovery to the Appellate Division, First Department.
Xerox Holdings will vigorously defend against this matter. At this time, it is premature to make any conclusion regarding the probability of incurring material losses in this litigation. Should developments cause a change in our determination as to an unfavorable outcome, or result in a final adverse judgment or settlement, there could be a material adverse effect on our results of operations, cash flows and financial position in the period in which such change in determination, judgment, or settlement occurs.
Xerox 2021 Form 10-Q 36


Other Litigation
1.Xerox Holdings Corporation v. Factory Mutual Insurance Company and Related Actions:
On March 10, 2021, Xerox Holdings Corporation (“XHC”) filed a complaint for breach of contract and declaratory judgment against Factory Mutual Insurance Company in Rhode Island Superior Court, Providence County seeking insurance coverage for business interruption losses resulting from the coronavirus/COVID-19 pandemic. The complaint alleges that defendant agreed to provide XHC with up to $ i 1 billion in per-occurrence coverage for losses resulting from pandemic-related loss or damage to certain real and other property, including business interruption loss resulting from insured property damage; that the pandemic had inflicted significant physical loss or damage to property of XHC and its direct and indirect customers; that XHC’s worldwide actual and projected losses through the end of 2020 totaled in excess of $ i 300 (and is still increasing); and that following XHC’s timely and proper claim in March 2020 for coverage under the “all risk” commercial property insurance policy it had purchased from defendant, defendant improperly denied and rejected coverage for most of the claim. The complaint seeks a jury trial, a declaratory judgment against defendant declaring that Xerox is entitled to full coverage of costs and losses under defendant’s policy and declaring that defendant is required to pay for such costs and losses, subject to any applicable limits; damages in an amount to be determined at trial; consequential damages; attorneys’ fees and costs; pre- and post-judgment interest; and other relief the Court deems just and proper. Also on March 10, 2021, subsidiaries of XHC filed similar complaints and related requests for arbitration in Toronto, London, and Amsterdam (see below).
XHC consented to defendant’s request for an extension until May 6, 2021 of its time in which to answer or otherwise respond to the complaint. The parties consented to assignment to the Court’s business calendar. At an initial conference on April 8, 2021, both parties informed the Court that they anticipate filing motions for judgment on the pleadings.
a.Canadian action
On March 10, 2021, plaintiffs Xerox Canada Inc. and Xerox Canada Ltd. filed a Notice of Action against Factory Mutual Insurance Company in the Ontario Superior Court of Justice in Toronto. On April 9, 2021, plaintiffs filed their Statement of Claim. Plaintiffs must serve both filings by September 10, 2021.
b.UK action
On March 10, 2021, plaintiffs Concept Group Limited, Continua Limited, Xerox Limited, and Xerox UK Limited filed a Claim Form against F.M. Insurance Company Limited in the High Court of Justice, Commercial Court, in London. Also on March 10, 2021, plaintiffs submitted  i two Requests for Arbitration, which were withdrawn after the parties agreed on March 31, 2021 that both liability and quantum of plaintiffs’ claims would be litigated in the Commercial Court proceeding.
c.Netherlands action
On March 10, 2021, plaintiffs Xerox Corporation and 20 of its European subsidiaries filed a Writ of Summons against FM Insurance Europe S.A. in the Amsterdam District Court. Also on March 10, 2021, plaintiffs submitted a Request for Arbitration, which was withdrawn after the parties agreed on April 12, 2021, that both liability and quantum of plaintiffs’ claims would be litigated in the District Court proceeding.
Guarantees
We have issued or provided approximately $ i 277 of guarantees as of March 31, 2021 in the form of letters of credit or surety bonds issued to i) support certain insurance programs; ii) support our obligations related to the Brazil contingencies; and iii) support certain contracts, primarily with public sector customers, which require us to provide a surety bond as a guarantee of our performance of contractual obligations.
In general, we would only be liable for the amount of these guarantees in the event we defaulted in performing our obligations under each contract; the probability of which we believe is remote. We believe that our capacity in the surety markets as well as under various credit arrangements (including our Credit Facility) is sufficient to allow us to respond to future requests for proposals that require such credit support.
Xerox 2021 Form 10-Q 37


Note 20 –  i Subsequent Events
Fuji Xerox Technology Agreement (TA)
As previously disclosed, our TA with Fuji Xerox (now known as FUJIFILM Business Innovation Corp.((Fuji Xerox)) expired on March 31, 2021. The TA included a provision that allowed Fuji Xerox continued use of the Xerox brand trademark for  i two years after the date of termination of the TA as it transitions to a new brand in exchange for an upfront prepaid fixed royalty of $ i 100. Fuji Xerox elected to continue its use of the Xerox brand trademark over the next  i two years and, therefore, made the upfront payment due under the amended agreement of $ i 100 in April 2021. We expect to recognize the revenue associated with this extended brand license ratably over the  i two year transition period. Accordingly, we expect any potential entry by Xerox for Xerographic products into the Fuji Xerox territory under the Xerox brand to be deferred to at least April 1, 2023. The product supply agreements with Fuji Xerox will continue to be effective despite the termination of the TA, and Fuji Xerox and Xerox will continue to operate as each other’s product supplier under existing or new purchase/supply agreements.
Acquisition
In April 2021, Xerox acquired an office equipment dealer in Canada for approximately $ i 30. This acquisition is part of Xerox's strategy of focusing on further penetrating the small-to-medium sized business (SMB) market through acquisitions of local area resellers and partners (including multi-brand dealers). We are currently assessing the purchase price allocation but expect the majority to be allocated to intangible assets and goodwill.


Xerox 2021 Form 10-Q 38


ITEM 2 — MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Throughout the Management’s Discussion and Analysis (MD&A), references to “Xerox Holdings” refer to Xerox Holdings Corporation and its consolidated subsidiaries while references to “Xerox” refer to Xerox Corporation and its consolidated subsidiaries. References herein to “we,” “us,” “our,” the “Company” refer collectively to both Xerox Holdings and Xerox unless the context suggests otherwise. References to "Xerox Holdings Corporation" refer to the stand-alone parent company and do not include its subsidiaries. References to "Xerox Corporation" refer to the stand-alone company and do not include subsidiaries.
Currently, Xerox Holdings' primary direct operating subsidiary is Xerox and Xerox reflects nearly all of Xerox Holdings' operations. Accordingly, the following MD&A primarily focuses on the operations of Xerox and is intended to help the reader understand Xerox's business and its results of operations and financial condition. The MD&A is provided as a supplement to, and should be read in conjunction with, the Condensed Consolidated Financial Statements and the accompanying notes. Throughout this MD&A, references are made to various notes in the Condensed Consolidated Financial Statements which appear in Item 1 of this Quarterly Report on Form 10-Q, and the information contained in such notes is incorporated by reference into the MD&A in the places where such references are made.
Xerox Holdings' other direct operating subsidiary is CareAR, Inc. (CareAR), a small SaaS solutions provider, which was acquired in 2020. CareAR incurred approximately $1 million of Selling, administrative and general expenses and $1 million of Amortization of intangible assets, net in first quarter of 2021. Due to their immaterial nature, and for ease of discussion, CareAR's expenses are included in this discussion with Xerox's costs and expenses.
Currency Impact
To understand the trends in the business, we believe that it is helpful to analyze the impact of changes in the translation of foreign currencies into U.S. Dollars on revenue and expenses. We refer to this analysis as "constant currency", “currency impact” or “the impact from currency.” This impact is calculated by translating current period activity in local currency using the comparable prior year period's currency translation rate. This impact is calculated for all countries where the functional currency is the local country currency. We do not hedge the translation effect of revenues or expenses denominated in currencies where the local currency is the functional currency. Management believes the constant currency measure provides investors an additional perspective on revenue trends. Currency impact can be determined as the difference between actual growth rates and constant currency growth rates.
Impact of COVID-19 on Our Business Operations
In response to the COVID-19 pandemic, we continue to prioritize the health and safety of our employees, customers and partners and support their needs so they can perform their work flawlessly, whether in the office or a remote location.
During the first quarter 2021, our business was still experiencing the impact of the pandemic, and the recovery in the near-term may be uneven and affected by the emergence of new variants of the virus and the resurgence of elevated COVID-19 cases in various countries and regions. However, we saw a gradual recovery of our revenues as businesses gained confidence in the progress to control the pandemic and resumed investments in new printing technology and services, and we saw a positive correlation between the roll-out of vaccinations, the return of employees to the office, and the gradual recovery of our page-volume driven Post sale revenues. We expect that measures to control the pandemic and expand economic activity will result in a moderate economic improvement in 2021. We also expect to continue our actions to mitigate the effects of the pandemic on our business operations and financial performance, and we have a strong balance sheet and sufficient liquidity, including access to our undrawn $1.8 billion revolver.
With our Project Own It transformation and cost savings, we have built a leaner and more flexible cost structure, but we also continue to focus our efforts on incremental actions to prioritize and preserve cash as we manage through the pandemic. These actions include the continued reduction of discretionary spend such as near-term targeted marketing programs, the use of contract employees, and the suspension of 401(k) matching contributions. In addition, in response to the COVID-19 pandemic, various governments continue to employ temporary measures to provide aid and economic stimulus directly to companies through cash grants and credits or indirectly through payments to temporarily furloughed employees. During first quarter 2021, we recognized savings of approximately $10 million from the use of such measures in the U.S., Canada and Europe. We continue to monitor government programs and actions being implemented or expected to be implemented to counter the economic impacts of the COVID-19 pandemic.
Xerox 2021 Form 10-Q 39


Overview
First Quarter 2021 Review
Total revenue of $1.71 billion for first quarter 2021 declined 8.1% from first quarter 2020, including a 2.3-percentage point favorable impact from currency. The decrease in revenue reflected a decrease of 13.4% in Post sale revenue, including a 2.2-percentage point favorable impact from currency, offset by an increase of 17.2% in Equipment sales revenue, including a 3.0-percentage point favorable impact from currency.
The COVID-19 pandemic impacted our first quarter 2021 revenues due to business closures and office building capacity restrictions that caused lower printing volumes on our devices. However, our revenues from equipment devices benefited from higher sales in the last month of the quarter corresponding with increased confidence in the progress of vaccinations and the gradual reopening of workplaces, compared to business shutdowns at the end of first quarter 2020.
Net income (loss) attributable to Xerox Holdings and adjusted1 Net income attributable to Xerox Holdings were as follows:
Three Months Ended March 31,
(in millions)20212020B/(W)
Net income (loss) attributable to Xerox Holdings$39 $(2)$41 
Adjusted(1) Net income attributable to Xerox Holdings
47 50 (3)
First quarter 2021 Net income attributable to Xerox Holdings increased $41 million as compared to first quarter 2020 primarily due to the prior year including a $60 million incremental provision to cover estimated write-offs on our trade and finance receivable portfolio from the economic disruption caused by the COVID-19 pandemic as well as lower Restructuring and related costs, net, Transaction and related costs, net and non-service retirement-related costs. These impacts were offset by lower Revenues that were only partially offset by lower operating costs and expenses. First quarter 2021 Adjusted1 net income attributable to Xerox Holdings decreased $3 million as compared to the prior year, reflecting lower revenues, which were only partially offset by lower operating costs and expenses and lower Income tax expense.
Cash flows provided by operating activities for the three months ended March 31, 2021 were $117 million, as compared to $173 million in the prior year period primarily reflecting lower working capital, net2, as well as a lower run-off of finance receivables. Cash used in investing activities for the three months ended March 31, 2021 was $17 million for capital expenditures. Cash used in financing activities for the three months ended March 31, 2021 was $318 million reflecting payments of $95 million on secured borrowings, $162 million on repurchases of our Common Stock and dividend payments of $54 million.
2021 Outlook
We continue to expect a modest recovery in 2021 and expect full year total revenues to increase to at least $7.2 billion, or approximately 2.5%, excluding the impact of currency. We are confident in our ability to generate cash and plan to continue our capital allocation policy of returning at least 50% of our annual free cash flow to shareholders, as disclosed in our 2020 Annual Report. We expect operating cash flows to be approximately $600 million, with capital expenditures of approximately $100 million and plan to opportunistically make share repurchases utilizing our remaining share repurchase authorization of approximately $338 million.
____________________________
(1)See the “Non-GAAP Financial Measures” section for an explanation of the non-GAAP financial measure.
(2)Working capital, net reflects Accounts receivable, net, Inventories and Accounts payable.






Xerox 2021 Form 10-Q 40


Financial Review
Revenues
Three Months Ended
March 31,
% of Total Revenue
(in millions)20212020% ChangeCC % Change20212020
Equipment sales$381 $325 17.2 %14.2 %22 %17 %
Post sale revenue1,329 1,535 (13.4)%(15.6)%78 %83 %
Total Revenue$1,710 $1,860 (8.1)%(10.4)%100 %100 %
Reconciliation to Condensed Consolidated Statements of Income (Loss):
Sales$602 $565 6.5 %4.2 %
Less: Supplies, paper and other sales(221)(240)(7.9)%(9.3)%
Equipment sales$381 $325 17.2 %14.2 %
Services, maintenance and rentals$1,053 $1,236 (14.8)%(18.0)%
Add: Supplies, paper and other sales221 240 (7.9)%(9.3)%
Add: Financing55 59 (6.8)%(8.6)%
Post sale revenue
$1,329 $1,535 (13.4)%(15.6)%
Americas$1,076 $1,239 (13.2)%(13.4)%63 %67 %
EMEA587 575 2.1 %(4.6)%34 %31 %
Other 47 46 2.2 %2.2 %%%
Total Revenue(1)
$1,710 $1,860 (8.1)%(10.4)%100 %100 %
_____________
CC - See "Currency Impact" section for a description of Constant Currency.
(1)Refer to the "Geographic Sales Channels and Product and Offerings Definitions" section.
Total revenue for the three months ended March 31, 2021 decreased 8.1% as compared to first quarter 2020, including a 2.3-percentage point favorable impact from currency and an approximate 1.0-percentage point favorable impact from 2020 partner dealer acquisitions.
The COVID-19 pandemic impacted our first quarter 2021 revenues due to business closures and office building capacity restrictions that caused lower printing volumes on our devices. However, our revenues from equipment devices benefited from higher sales in the last month of the quarter corresponding with increased confidence in the progress of vaccinations and the gradual reopening of workplaces, compared to business shutdowns at the end of first quarter 2020.
Sequentially, the rate of decline of our revenues moderated during first quarter 2021. Geographically, the rate of revenue decline moderated more significantly in our EMEA operations, partially due to the region's earlier and more expansive shutdown in the prior year, as well as its higher mix of SMB businesses which have recovered more rapidly with the progress of vaccinations and the control of the pandemic, while our North American operations include a higher proportion of Enterprise customers who are experiencing a slower pace of return to large office buildings. Our EMEA revenues were also favorably impacted by prior year acquisitions in the region
Total revenue for the three months ended March 31, 2021 reflected the following:
Post sale revenue
Post sale revenue primarily reflects contracted services, equipment maintenance, supplies and financing. These revenues are associated not only with the population of devices in the field, which are affected by installs and removals, but also by the page volumes generated from the usage of such devices and the revenue per printed page. Post sale revenue also includes transactional IT hardware sales and implementation services primarily from our XBS organization. For the three months ended March 31, 2021 Post sale revenue decreased 13.4% as compared to first quarter 2020, including a 2.2-percentage point favorable impact from currency. The COVID-19 pandemic impacted our Post sale revenue during the first quarter 2021 due to office closures. The decline in Post sale revenue reflected the following:
Services, maintenance and rentals revenue includes rental and maintenance revenue (including bundled supplies) as well as the post sale component of the document services revenue from our Xerox Services offerings. While these revenues are contractual in nature, our bundled services contracts generally include a
Xerox 2021 Form 10-Q 41


minimum fixed charge and a significant variable component based on print volumes. The rate of decline of these revenues moderated as compared to fourth quarter 2020, benefiting from an easier compare (as the prior year was affected by shutdowns at the end of the quarter), but also corresponding with a modest sequential increase in page volumes as the quarter progressed consistent with the rollout of vaccinations, which allowed more employees to return to their offices. For the three months ended March 31, 2021, these revenues decreased 14.8% as compared to first quarter 2020, including a 3.2-percentage point favorable impact from currency. The decline at constant currency1 reflected a lower population of devices (which is partially associated with lower installs in prior periods), an ongoing competitive price environment, and lower page volumes (including a higher mix of lower average-page-volume products).
Supplies, paper and other sales includes unbundled supplies and other sales. For the three months ended March 31, 2021, these revenues decreased 7.9% as compared to first quarter 2020, including a 1.4-percentage point favorable impact from currency and reflected primarily lower supplies revenues associated with lower page volume trends partially offset by higher IT revenues from IT dealers acquired in the prior year in the U.K. and Canada, and from our XBS sales unit The decrease in supplies was impacted by lower sales through indirect channels. The rate of decline of these revenues improved as compared to fourth quarter 2020, as resellers, moderately softened their cash control and inventory restrictions consistent with gradual indications of improvement in the control of the pandemic.
Financing revenue is generated from financed equipment sale transactions. For the three months ended March 31, 2021, these revenues declined 6.8%, reflecting a continued decline in the finance receivables balance due to lower equipment sales in prior periods and included a 1.8-percentage point favorable impact from currency. XFS lease originations increased in the quarter as compared to first quarter 2020, due to a higher level of lease originations for our XBS sales unit.
____________
(1)See the “Non-GAAP Financial Measures” section for an explanation of the non-GAAP financial measure.
Equipment sales revenue
 Three Months Ended
March 31,
% of Equipment Sales
(in millions)20212020% ChangeCC % Change20212020
Entry$68 $48 41.7%35.9%18%15%
Mid-range238 206 15.5%13.2%63%63%
High-end70 67 4.5%2.0%18%21%
Other25.0%25.0%1%1%
Equipment sales$381 $325 17.2%14.2%100%100%
_____________
CC - See "Currency Impact" section for a description of Constant Currency.
Note: During first quarter 2021, we revised the classification of equipment sales revenue by category for our XBS sales unit. Refer to the Equipment Sales Revenue - Classification Update section, for the revision of prior periods based on the new classification.
Equipment sales revenue increased 17.2% for the three months ended March 31, 2021 as compared to first quarter 2020, including a 3.0-percentage point favorable impact from currency partially offset by the impact of price declines of less than 5%. The increase is partially the result of a favorable compare to the first quarter 2020, when the COVID-19 pandemic resulted in sudden business closures during the last month of the quarter when, historically, a significant portion of our equipment is sold. In addition, these revenues increased at a higher pace through our indirect channels in the U.S. and EMEA, in part due to resellers modestly rebuilding inventories as demand increased with business reopenings. We also continue to see higher sales to our government customers in the U.S., and a higher mix of our revenues coming from lower-end devices as a result of trends associated with the COVID-19 pandemic. The growth at constant currency1 reflected the following:
Entry - The increase was driven primarily by higher demand for our lower-end printers and MFPs through our indirect channels in the U.S. and in EMEA, including higher installs related to government deals in the developing regions of EMEA.
Mid-range - The increase was driven primarily by higher demand as a result of business reopenings as compared to business shutdowns that reduced purchases of office devices in the prior year. In addition, through the quarter, we saw a gradual narrowing of the gap to pre-pandemic levels consistent with the progress of vaccinations and office and school reopenings.
Xerox 2021 Form 10-Q 42


High-end - The increase reflected primarily improvement in sales of devices in the lower-end of the range, to SMB customers, while sales of larger production engines continued to be depressed as a result of our clients' delayed capital investment decisions.
Total Installs
Installs reflect new placement of devices only (i.e., measure does not take into account removal of devices which may occur as a result of contract renewals or cancellations). Revenue associated with equipment installations may be reflected up-front in Equipment sales or over time either through rental income or as part of our Xerox Services revenues (which are both reported within our Post sale revenues), depending on the terms and conditions of our agreements with customers. Installs include activity from Xerox Services and Xerox and non-Xerox branded products installed by our XBS sales unit. Detail by product group (see Geographic Sales Channels and Product and Offerings Definitions) is shown below.
Installs for the first quarter 2021:
Entry
9% increase in color multifunction devices reflecting higher installs of ConnectKey devices through our indirect channels in EMEA, partially offset by lower installs through our U.S. resellers.
97% increase in black-and-white multifunction devices reflecting higher activity primarily from indirect channels in the U.S and from developing regions in EMEA. The increase is primarily driven by higher sales of low-end devices including large order government deals from developing markets in EMEA.
Mid-Range(1)
11% increase in mid-range color installs primarily reflecting higher installs of our recently launched PrimeLink entry-production color devices and our new-generation of ConnectKey multi-function printers.
13% increase in mid-range black-and-white installs reflecting higher installs of our recently launched PrimeLink light-production devices and our new-generation of ConnectKey multi-function devices.
High-End(1)
46% increase in high-end color installs reflecting primarily growth from our lower-end Versant devices and our Iridesse systems partially offset by lower installs of our higher-end production presses.
18% increase in high-end black-and-white systems reflecting higher installs of our Nuvera devices related to cyclical account refreshes in the U.S.
_____________
(1)Mid-range and High-end color installations exclude Fuji Xerox (now known as FUJIFILM Business Innovation Corp. (Fuji Xerox)) digital front-end sales; including Fuji Xerox digital front-end sales Mid-range color devices increased 12% and High-end color systems increased 44%.

Xerox 2021 Form 10-Q 43


Geographic Sales Channels and Product and Offerings Definitions
Our business is aligned to a geographic focus and is primarily organized on the basis of go-to-market sales channels, which are structured to serve a range of customers for our products and services. In 2019 we changed our geographic structure to create a more streamlined, flatter and more effective organization, as follows:
Americas, which includes our sales channels in the U.S. and Canada, as well as Mexico, and Central and South America.
EMEA, which includes our sales channels in Europe, the Middle East, Africa and India.
Other, primarily includes sales to and royalties from Fuji Xerox, and our licensing revenue.
Our products and offerings include:
“Entry”, which includes A4 devices and desktop printers. Prices in this product group can range from approximately $150 to $3,000.
“Mid-Range”, which includes A3 Office and Light Production devices that generally serve workgroup environments in mid to large enterprises. Prices in this product group can range from approximately $2,000 to $75,000+.
“High-End”, which includes production printing and publishing systems that generally serve the graphic communications marketplace and large enterprises. Prices for these systems can range from approximately $30,000 to $1,000,000+.
Xerox Services, includes solutions and services that span from managing print to automating processes to managing content. Our primary offerings are Intelligent Workplace Services (IWS), as well as Digital and Cloud Print Services (including centralized print services) and Communication and Marketing Solutions.
Equipment Sales Revenue - Classification Update
During first quarter 2021, we revised the classification of equipment sales revenue by category for our XBS sales unit to conform the classification of devices across Xerox sales channels. The revision had no impact on reported total equipment sales revenue.
2020 Equipment Sales Revenue As Reported
(in millions)Q1Q2Q3Q4FY
Entry$40 $34 $55 $59 $188 
Mid-range218 209 291 325 1,043 
High-end64 64 69 115 312 
Other 11 21 
Equipment Sales Revenue$325 $310 $419 $510 $1,564 

Change
(in millions)Q1Q2Q3Q4FY
Entry$$10 $11 $11 $40 
Mid-range(12)(14)(15)(16)(57)
High-end13 
Other
Equipment Sales Revenue$— $— $— $— $— 

2020 Equipment Sales Revenue As Revised
(in millions)Q1Q2Q3Q4FY
Entry$48 $44 $66 $70 $228 
Mid-range206 195 276 309 986 
High-end67 67 72 119 325 
Other 12 25 
Equipment Sales Revenue$325 $310 $419 $510 $1,564 

Xerox 2021 Form 10-Q 44


Costs, Expenses and Other Income
Summary of Key Financial Ratios
The following is a summary of key financial ratios used to assess our performance:
Three Months Ended March 31,
(in millions)20212020B/(W)
Gross Profit$611 $712 $(101)
RD&E74 84 10 
SAG448 541 93 
Equipment Gross Margin27.9 %26.3 %1.6 pts.
Post sale Gross Margin38.0 %40.8 %(2.8)pts.
Total Gross Margin35.7 %38.3 %(2.6)pts.
RD&E as a % of Revenue4.3 %4.5 %0.2 pts.
SAG as a % of Revenue26.2 %29.1 %2.9 pts.
Pre-tax Income (Loss)$53 $(5)$58 
Pre-tax Income (Loss) Margin3.1 %(0.3)%3.4 pts.
Adjusted(1) Operating Profit
$89 $87 $
Adjusted(1) Operating Margin
5.2 %4.7 %0.5 pts.
_____________
(1)See the “Non-GAAP Financial Measures” section for an explanation of the non-GAAP financial measure.
Pre-tax Income Margin
First quarter 2021 pre-tax income margin of 3.1% increased by 3.4-percentage points as compared to first quarter 2020. The increase primarily reflected the impact of higher adjusted1 operating margin (see below) as well as lower Restructuring and related costs, net, Transaction and related costs, net and lower Other expenses, net, partially offset by higher Amortization of intangible assets.
Adjusted1 Operating Margin
First quarter 2021 adjusted1 operating margin of 5.2% increased by 0.5-percentage points as compared to first quarter 2020 reflecting an approximate 3.7-percentage point favorable impact from lower bad debt expense due to a higher provision in the prior year to reflect the expected impact to our trade and finance receivable portfolio as a result of the economic disruption caused by the COVID-19 pandemic. This benefit was partially offset by the impact of lower revenues, primarily due to the effect of the COVID-19 pandemic on our business. The impact of these lower revenues was in turn partially mitigated by cost and expense reductions associated with our Project Own It transformation actions, and additional savings from various other cost reductions to mitigate the impact of the pandemic. These actions include savings of approximately $10 million from temporary government assistance measures and reductions in discretionary spend such as the use of contract employees and the suspension of 401(k) matching contributions.
______________
(1)Refer to the Operating Income and Margin reconciliation table in the "Non-GAAP Financial Measures" section.
Gross Margin
First quarter 2021 gross margin of 35.7% decreased by 2.6-percentage points as compared to first quarter 2020, reflecting the impact of lower revenues, primarily as a result of the effect of the COVID-19 pandemic, including a lower mix of our higher-margin post sale stream (which is most affected by business closures and the associated lower print volumes), as well as the impact of the ongoing competitive price environment. These headwinds were partially offset by the cost savings from our Project Own It transformation actions as well as the additional cost reduction actions to mitigate the impact of the pandemic, including savings of approximately $7 million from temporary government assistance measures and reductions in discretionary spend such as the use of contract employees and the suspension of 401(k) matching contributions.
Xerox 2021 Form 10-Q 45


First quarter 2021 Equipment gross margin of 27.9% increased by 1.6-percentage points as compared to first quarter 2020, reflecting higher sales in the last month of the quarter, as well as the benefit of cost reductions from Project Own It and favorable transaction currency partially offset by an unfavorable mix of growth in low-end devices and the impact of targeted price promotions.
First quarter 2021 Post sale gross margin of 38.0% decreased by 2.8-percentage points as compared to first quarter 2020, reflecting the impact of lower revenues (primarily as a result of COVID-19 related business closures impacting page volumes) and price erosion on contract renewals, partially offset by productivity and cost savings and restructuring savings associated with Project Own It transformation actions, as well as savings from additional cost reduction actions to mitigate the impact of the pandemic.
Research, Development and Engineering Expenses (RD&E)
 Three Months Ended
March 31,
(in millions)20212020Change
R&D$59 $68 $(9)
Sustaining engineering15 16 (1)
Total RD&E Expenses$74 $84 $(10)
First quarter 2021 RD&E as a percentage of revenue of 4.3% decreased by 0.2-percentage points as compared to first quarter 2020, as a result of cost reductions that outpaced the rate of revenue declines.
RD&E of $74 million decreased $10 million as compared to first quarter 2020 reflecting savings from simplification and rationalization in our core technology, as well as a favorable impact from the program cycle of recent launches and the timing of projects.
Selling, Administrative and General Expenses (SAG)
First quarter 2021 SAG as a percentage of revenue of 26.2% decreased by 2.9-percentage points as compared to first quarter 2020, primarily as a result of an approximate 3.7-percentage point favorable impact from lower bad debt expense due to a higher provision in the prior year to reflect the expected impact to our trade and finance receivable portfolio as a result of the economic disruption caused by the COVID-19 pandemic. The remaining increase was primarily due to the impact of lower revenues, which was only partially offset by lower expenses as a result of cost savings and restructuring associated with our Project Own It transformation actions, and savings from additional cost reduction actions to mitigate the impact of the pandemic. These actions include savings from temporary government assistance measures and reductions in discretionary spend such as near-term targeted marketing programs, and the suspension of 401(k) matching contributions.
First quarter 2021 SAG of $448 million decreased by $93 million as compared to first quarter 2020, reflecting primarily lower bad debt expenses, as well as cost savings and restructuring savings associated with our Project Own It transformation actions and from additional cost reduction actions to mitigate the impact of the pandemic, as described above, partially offset by higher compensation related accrual expenses (consistent with higher expected operating results), an approximate $10 million impact from translation currency, and higher expenses from prior year acquisitions.
Our bad debt provision of $10 million decreased by $64 million as compared to first quarter 2020, primarily due to the prior year reflecting an approximate $60 million incremental provision to cover estimated write-offs on our trade and finance receivable portfolio from the economic disruption caused by the COVID-19 pandemic. Subsequent to first quarter 2020 and through first quarter 2021, actual write-offs incurred to date have lagged expectations but remain in line with our original projections over the life of the lease portfolio and consistent with future expectations regarding our estimated impacts from the COVID-19 pandemic. Accordingly, our reserves as a percent of receivables have remained fairly consistent subsequent to the first quarter 2020 charge. We continue to monitor developments regarding the pandemic, including business closures and mitigating government support actions and as a result our reserves may need to be updated in future periods. On a trailing twelve-month basis (TTM), bad debt expense was approximately 1.3% of total receivables, which is nearly back to the pre-pandemic trend of approximately 1.0% and reflects the consistent level of reserves subsequent to the first quarter 2020 charge.

Xerox 2021 Form 10-Q 46


Restructuring and Related Costs, Net
We incurred Restructuring and related costs, net of $17 million for the first quarter 2021, as compared to $41 million for first quarter 2020. These costs were primarily related to the implementation of initiatives under our business transformation projects including Project Own It. The following is a breakdown of those costs:
Three Months Ended
March 31,
(in millions)20212020
Severance(1)
$14 $32 
Asset impairments(2)
10 
Other contractual termination costs(3)
Net reversals(4)
(4)(6)
Restructuring and asset impairment costs21 29 
Retention related severance/bonuses(5)
(4)
Contractual severance costs(6)
— 
Consulting and other costs(7)
— 
Total$17 $41 
_____________
(1)Reflects headcount reductions of approximately 350 and 300 employees worldwide in first quarter 2021 and 2020, respectively.
(2)Primarily related to the exit and abandonment of leased and owned facilities. The charge includes the accelerated write-off of $1 million and $1 million for leased right-of-use assets and $9 million and $1 million for owned assets upon exit from the facilities, net of any potential sublease income and other recoveries, including potential sales, in the first quarter of 2021 and 2020, respectively.
(3)Primarily includes additional costs incurred upon the exit from our facilities including decommissioning costs and associated contractual termination costs.
(4)Reflects net reversals for changes in estimated reserves from prior period initiatives.
(5)Includes retention related severance and bonuses for employees expected to continue working beyond their minimum notification period before termination. The $4 million credit in first quarter 2021 reflects a change in estimate.
(6)Amounts primarily reflect estimated severance and other related costs we were contractually required to pay in connection with employees transferred as part of the shared service arrangement entered into with HCL Technologies in the first quarter 2019.
(7)Represents professional support services associated with our business transformation initiatives.
First quarter 2021 actions impacted several functional areas, with approximately 25% focused on gross margin improvements, approximately 65% focused on SAG reductions and the remainder focused on RD&E optimization.
First quarter 2020 actions impacted several functional areas, with approximately 40% focused on gross margin improvements, approximately 50% focused on SAG reductions and the remainder focused on RD&E optimization.
The Restructuring and related costs, net reserve balance as of March 31, 2021 for all programs was $76 million, which is expected to be paid over the next twelve months.
Refer to Note 10 - Restructuring Programs in the Condensed Consolidated Financial Statements for additional information regarding our restructuring programs.
Transaction and Related Costs, Net
Transaction and related costs, net primarily reflect costs from third party providers for professional services associated with certain strategic M&A projects. There were no Transaction and related costs, net incurred during first quarter 2021 as compared to $17 million of Transaction and related costs, net, during the first quarter of 2020 primarily related to legal and other professional costs associated with the terminated proposal to acquire HP Inc.
Amortization of Intangible Assets
Amortization of intangible assets for the three months ended March 31, 2021 of $15 million increased by $4 million as compared to the prior year period primarily related to intangible assets associated with our 2020 partner dealer acquisitions in the U.K. and Canada.
Worldwide Employment
Worldwide employment was approximately 24,600 as of March 31, 2021 and decreased by approximately 5001 from December 31, 2020. The reduction resulted from net attrition (attrition net of gross hires), of which a large portion is not expected to be back filled, as well as the impact of organizational changes.
_____________
(1)Decrease based on revised headcount at December 31, 2020 of 25,100 from 24,700 due to the change in definition of full-time equivalent employee.
Xerox 2021 Form 10-Q 47


Other Expenses, Net
 Three Months Ended
March 31,
(in millions)20212020
Non-financing interest expense$24 $21 
Interest income(1)(8)
Non-service retirement-related costs(20)
Gains on sales of businesses and assets— (1)
Currency losses, net
Contract termination costs - IT services— 
All other expenses, net(1)
Other expenses, net$$23 
Non-Financing Interest Expense
First quarter 2021 non-financing interest expense of $24 million was $3 million higher than first quarter 2020. When combined with financing interest expense (Cost of financing), total interest expense increased by $1 million from first quarter 2020 primarily reflecting a lower average debt balance.
Refer to Note 11 - Debt in the Condensed Consolidated Financial Statements, for additional information regarding debt activity and the interest expense.
Interest Income
Interest income for the three months ended March 31, 2021 was $7 million lower than first quarter 2020, primarily due to lower interest rates.
Non-Service Retirement-Related Costs
Non-service retirement-related costs for the three months ended March 31, 2021 were $21 million lower than first quarter 2020, primarily driven by lower discount rates, as well as higher expected returns on plan assets due to higher asset balances, and lower losses from pension settlements in the U.S.
Refer to Note 14 - Employee Benefit Plans in the Condensed Consolidated Financial Statements, for additional information regarding non-service retirement-related costs.
Income Taxes
First quarter 2021 effective tax rate was 26.4%. On an adjusted1 basis, first quarter 2021 effective tax rate was 27.7%. This rate was higher than the U.S. federal statutory tax rate of 21% primarily due to state taxes and the geographical mix of earnings. The adjusted1 effective tax rate excludes the tax impacts associated with the following charges: Restructuring and related costs, net, Amortization of intangible assets, non-service retirement-related costs and other discrete, unusual or infrequent items as described in our Non-GAAP Financial Measures section.
First quarter 2020 effective tax rate was 20.0%. On an adjusted1 basis, first quarter 2020 effective tax rate was 29.4%. This rate was higher than the U.S. federal statutory tax rate of 21% primarily due to state taxes and the geographical mix of earnings as well as the increased impact from various non-deductible and discrete items on lower pre-tax income. The adjusted1 effective tax rate excludes the tax impacts associated with the following charges: Restructuring and related costs, net, Amortization of intangible assets, Transaction and related costs, net, non-service retirement-related costs and other discrete, unusual or infrequent items as described in our Non-GAAP Financial Measures section.
Our effective tax rate is based on nonrecurring events as well as recurring factors, including the taxation of foreign income. In addition, our effective tax rate will change based on discrete or other nonrecurring events that may not be predictable.
_____________
(1)Refer to the Effective Tax Rate reconciliation table in the "Non-GAAP Financial Measures" section.
Equity in Net Income of Unconsolidated Affiliates
Investment in Affiliates, at Equity largely consists of several minor investments in entities in the Middle East region. There was no Equity in net income of unconsolidated affiliates for the three months ended March 31, 2021, as compared to $2 million of Equity income of unconsolidated affiliates for the three months ended March 31, 2020.
Xerox 2021 Form 10-Q 48


Net Income (Loss)
First quarter 2021 Net income attributable to Xerox Holdings was $39 million, or $0.18 per diluted share. On an adjusted1 basis, Net income attributable to Xerox Holdings was $47 million, or $0.22 per diluted share. First quarter 2021 adjustments to Net income included Restructuring and related costs, net, Amortization of intangible assets, and non-service retirement-related costs (see Non-GAAP Financial Measures).
First quarter 2020 Net loss attributable to Xerox Holdings was $2 million, or $(0.03) per diluted share. On an adjusted1 basis, Net income attributable to Xerox Holdings was $50 million, or $0.21 per diluted share. Both amounts included the impact of the approximately $60 million pre-tax increase in bad debt expense (approximately $43 million after-tax) as compared to first quarter 2019, primarily reflecting the expected impact to our customer base and related outstanding receivable portfolio as a result of the economic disruption caused by the COVID-19 pandemic. First quarter 2020 adjustments to Net loss included Restructuring and related costs, net, Amortization of intangible assets, Transaction and related costs, net as well as non-service retirement-related costs and other discrete, unusual or infrequent items (see Non-GAAP Financial Measures).
Refer to Note 18 - Earnings (Loss) per Share in the Condensed Consolidated Financial Statements, for additional information regarding the calculation of basic and diluted earnings (loss) per share.
_____________
(1)Refer to the Net Income (Loss) and EPS reconciliation table in the "Non-GAAP Financial Measures" section.
Other Comprehensive Loss
First quarter 2021 Other Comprehensive Loss, Net Attributable to Xerox was $3 million and included the following: i) net translation adjustment losses of $51 million reflecting the weakening of the Euro against the U.S. Dollar that was only partially offset by the strengthening of the GBP and CAD dollar; ii) $7 million of net unrealized losses; and iii) $55 million of net gains from the changes in defined benefit plans primarily due to net actuarial gains as a result of higher discount rates in the U.S. This compares to Other Comprehensive Loss, Net Attributable to Xerox of $138 million for the first quarter 2020, which reflected the following: i) net translation adjustment losses of $197 million reflecting the significant weakening of our major foreign currencies against the U.S. Dollar; ii) $54 million of net gains from the changes in defined benefit plans; and iii) $5 million net unrealized gains.
Refer to Note 17 - Other Comprehensive Income (Loss) in the Condensed Consolidated Financial Statements, for the components of Other Comprehensive Loss, Note 12 - Financial Instruments in the Condensed Consolidated Financial Statements, for additional information regarding unrealized (losses) gains, net, and Note 14 - Employee Benefit Plans in the Condensed Consolidated Financial Statements, for additional information regarding net changes in our defined benefit plans.
_____________
(1)AOCL - Accumulated other comprehensive loss.
New Business Strategy
As disclosed in our 2020 Annual Report, in January 2021 we announced our intention to stand up our Software, Financing and Innovation businesses as separate units by 2022. At this stage, the operations and financial results for these units continue to be managed by and reported in our “go-to-market” (GTM) sales channels. We have begun the process of reorganizing these new units from the GTM units but we have not progressed to the point where we have discrete and complete financial information for these new businesses. Accordingly, the chief operating decision maker (CODM) and management continue to manage the Company’s operations, including the products and services from these units, through the GTM sales channels and as result, we continue to have one operating and reportable segment.
We expect that the business and financial information for these new units, as well as the operational management of these businesses, will continue to be refined and improved during 2021. Accordingly, a reassessment of our operating segments may be required later in 2021.
Xerox 2021 Form 10-Q 49


Capital Resources and Liquidity
Our first quarter financial results were impacted by COVID-19 related business closures and office building capacity restrictions. However, we believe we have sufficient liquidity to manage the business through the economic disruption caused by this pandemic:
A majority of our business is contractually based and most of our bundled services contracts include not only a variable component linked to print volumes, but also a fixed minimum, which provides us with a continuing stream of operating cash flow.
As of March 31, 2021, total cash, cash equivalents and restricted cash were $2,461 million and, apart from the restricted cash of $82 million, was readily accessible for use. We have access to an undrawn $1.8 billion Credit Facility that matures in August 2022.
We have utilized a combination of capital markets financing and securitization to refinance all of our 2021 debt maturities, significantly reducing our near-term debt commitments and improving our liquidity.
We continue to focus our efforts on incremental actions to prioritize and preserve cash as we manage through the pandemic. These actions include the use of available temporary government assistance measures and furlough programs and the reduction of discretionary spend such as near-term targeted marketing programs and the suspension of 401(k) matching contributions.

Cash Flow Analysis
The following summarizes our cash, cash equivalents and restricted cash:
 Three Months Ended
March 31,
Change
(in millions)20212020
Net cash provided by operating activities$117 $173 $(56)
Net cash used in investing activities(17)(214)197 
Net cash used in financing activities(318)(60)(258)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(12)(29)17 
Decrease in cash, cash equivalents and restricted cash(230)(130)(100)
Cash, cash equivalents and restricted cash at beginning of period2,691 2,795 (104)
Cash, Cash Equivalents and Restricted Cash at End of Period$2,461 $2,665 $(204)
Cash Flows from Operating Activities
Net cash provided by operating activities was $117 million in first quarter 2021. The $56 million decrease in operating cash from the prior year period was primarily due to the following:
$82 million decrease from lower accounts payable primarily due to decreased spending and the year-over-year timing of supplier and vendor payments.
$74 million decrease from accounts receivable primarily due to a lower sequential revenue decrease as compared to the prior year partially offset by timing of collections.
$56 million decrease from a lower net run-off of finance receivables due to an increased level of XFS lease originations for our XBS sales unit.
$38 million decrease from derivatives primarily related to settlements of EUR/GBP derivative contracts reflecting the significant movements in rates year-over-year.
$108 million increase from inventory primarily due to significant usage in 2020 as inventory levels increased with the onset of the COVID-19 pandemic.
$72 million increase from accrued compensation primarily related to the year-over-year timing of employee incentive payments.
Cash Flows from Investing Activities
Net cash used in investing activities was $17 million in first quarter 2021. The $197 million change from the prior year period was primarily due to acquisitions of $193 million in the prior year compared to no acquisitions in the current year.
Xerox 2021 Form 10-Q 50


Cash Flows from Financing Activities
Net cash used in financing activities was $318 million in first quarter 2021. The $258 million increase in the use of cash from the prior year period was primarily due to the following:
$162 million increase due to share repurchases in the current year compared to no share repurchases in the prior year.
$97 million increase from net debt activity primarily due to payments of $94 million on secured financing arrangements in the current year compared to no payments in the prior year.
Cash, Cash Equivalents and Restricted Cash
Refer to Note 5 - Supplementary Financial Information in the Condensed Consolidated Financial Statements for additional information regarding Cash, cash equivalents and restricted cash.
Operating Leases
We have operating leases for real estate and vehicles in our domestic and international operations and certain equipment in our domestic operations. Additionally, we have identified embedded operating leases within certain supply chain contracts for warehouses, primarily within our domestic operations. Our leases have remaining terms of up to twelve years and a variety of renewal and/or termination options. As of March 31, 2021 and December 31, 2020, total operating liabilities were $310 million and $333 million, respectively.
Refer to Note 9 - Lessee in the Condensed Consolidated Financial Statements for additional information regarding our leases accounted under lessee accounting.
Debt and Customer Financing Activities
The following summarizes our debt:
(in millions)March 31, 2021December 31, 2020
Xerox Holdings Corporation$1,500 $1,500 
Xerox Corporation2,200 2,200 
Xerox - Other Subsidiaries(1)
673 767 
Subtotal - Principal debt balance4,373 4,467 
Debt issuance costs
Xerox Holdings Corporation(12)(13)
Xerox Corporation(10)(11)
Xerox - Other Subsidiaries(1)
(3)(3)
Subtotal - Debt issuance costs(25)(27)
Net unamortized premium
Fair value adjustments(2)
     - terminated swaps
Total Debt$4,352 $4,444 
_____________
(1)Represents secured debt issued by subsidiaries of Xerox Corporation as part of the securitization of Finance Receivables - Refer to Note 11 - Debt in the Condensed Consolidated Financial Statements for additional information.
(2)Fair value adjustments normally include the following: (i) fair value adjustments to debt associated with terminated interest rate swaps, which are being amortized to interest expense over the remaining term of the related notes; and (ii) changes in fair value of hedged debt obligations attributable to movements in benchmark interest rates. Hedge accounting requires hedged debt instruments to be reported inclusive of any fair value adjustment.
Refer to Note 11 - Debt in the Condensed Consolidated Financial Statements for additional information regarding debt.
Xerox 2021 Form 10-Q 51


Finance Assets and Related Debt
The following represents our total finance assets, net associated with our lease and finance operations:
(in millions)March 31, 2021December 31, 2020
Total finance receivables, net(1)
$3,077 $3,165 
Equipment on operating leases, net277 296 
Total Finance Assets, net(2)
$3,354 $3,461 
_____________
(1)Includes (i) Billed portion of finance receivables, net, (ii) Finance receivables, net and (iii) Finance receivables due after one year, net as included in our Condensed Consolidated Balance Sheets.
(2)The change from December 31, 2020 includes a decrease of $43 million due to currency.
Our lease contracts permit customers to pay for equipment over time rather than at the date of installation; therefore, we maintain a certain level of debt (that we refer to as financing debt) to support our investment in these lease contracts, which are reflected in total finance assets, net. For this financing aspect of our business, we maintain an assumed 7:1 leverage ratio of debt to equity as compared to our finance assets.
Based on this leverage, the following represents the breakdown of total debt between financing debt and core debt:
(in millions)March 31, 2021December 31, 2020
Finance receivables debt(1)
$2,692 $2,769 
Equipment on operating leases debt243 259 
Financing debt2,935 3,028 
Core debt1,417 1,416 
Total Debt$4,352 $4,444 
____________________________
(1)Finance receivables debt is the basis for our calculation of "Cost of financing" expense in the Condensed Consolidated Statements of Income (Loss).
Sales of Accounts Receivable
Activity related to sales of accounts receivable is as follows:  
 Three Months Ended
March 31,
(in millions)20212020
Estimated decrease to operating cash flows(1)
$(27)$(77)
_____________
(1)Represents the difference between current and prior period accounts receivable sales adjusted for the effects of currency.
Refer to Note 6 - Accounts Receivable, Net in the Condensed Consolidated Financial Statements for additional information regarding our accounts receivable sales arrangements.

Xerox 2021 Form 10-Q 52


Liquidity and Financial Flexibility
We manage our worldwide liquidity using internal cash management practices, which are subject to i) the statutes, regulations and practices of each of the local jurisdictions in which we operate, ii) the legal requirements of the agreements to which we are a party and iii) the policies and cooperation of the financial institutions we utilize to maintain and provide cash management services.
Our principal debt maturities are spread over the next five years as follows:
(in millions)Xerox Holdings CorporationXerox Corporation
Xerox - Other Subsidiaries(1)
Total
2021 Q2$— $— $107 $107 
2021 Q3— — 101 101 
2021 Q4— — 93 93 
2022— 300 289 589 
2023— 1,000 83 1,083 
2024— 300 — 300 
2025750 — — 750 
2026 and thereafter750 600 — 1,350 
Total(2)
$1,500 $2,200 $673 $4,373 
_____________
(1)Represents secured debt issued by subsidiaries of Xerox Corporation as part of securitization of Finance Receivables - Refer to Note 11 - Debt in the Condensed Consolidated Financial Statements for additional information.
(2)Includes fair value adjustments.
Treasury Stock
In the first quarter 2021 Xerox Holdings repurchased 6.7 million shares of our common stock for an aggregate cost of $162 million, including fees. The cumulative total of shares repurchased by Xerox Holdings under the current share repurchase program is 31.4 million shares for an aggregate cost of $762 million, including fees. As of March 31, 2021, the remaining share repurchase authorization is approximately $338 million.
Shared Services Arrangement with HCL Technologies
In March 2019, as part of Project Own It, Xerox entered into a shared services arrangement with HCL Technologies ("HCL") pursuant to which we transitioned certain global administrative and support functions, including, among others, selected information technology and finance functions, from Xerox to HCL. This transition was expected to be completed during 2020, however, it sustained some delays caused by the COVID-19 pandemic, and it is now expected to be finalized by the end of 2021. HCL is expected to make certain ongoing investments in software, tools and other technology to consolidate, optimize and automate the transferred functions with the goal of providing improved service levels and significant cost savings. The shared services arrangement with HCL includes a remaining aggregate spending commitment of approximately $1 billion over the next 5 years. However, we can terminate the arrangement at any time at our discretion, subject to payment of termination fees that decline over the term, or for cause.
We incurred net charges of approximately $50 million and $45 million during first quarter 2021 and 2020, respectively. The increase of approximately $5 million was primarily due to scope changes and currency. The cost has been allocated to the various functional expense lines in the Condensed Consolidated Statements of Income (Loss) based on an assessment of the nature and amount of the costs incurred for the various transferred functions prior to their transfer to HCL.


Xerox 2021 Form 10-Q 53


Financial Risk Management
We are exposed to market risk from foreign currency exchange rates and interest rates, which could affect operating results, financial position and cash flows. We manage our exposure to these market risks through our regular operating and financing activities and, when appropriate, through the use of derivative financial instruments. We utilize derivative financial instruments to hedge economic exposures, as well as to reduce earnings and cash flow volatility resulting from shifts in market rates. We enter into limited types of derivative contracts, including interest rate swap agreements, interest rate caps, foreign currency spot, forward and swap contracts and net purchased foreign currency options to manage interest rate and foreign currency exposures. Our primary foreign currency market exposures include the Japanese Yen, Euro and U.K. Pound Sterling. The fair market values of all our derivative contracts change with fluctuations in interest rates and/or currency exchange rates and are designed so that any changes in their values are offset by changes in the values of the underlying exposures. Derivative financial instruments are held solely as risk management tools and not for trading or speculative purposes. The related cash flow impacts of all of our derivative activities are reflected as cash flows from operating activities.
We are required to recognize all derivative instruments as either assets or liabilities at fair value in the balance sheet. As permitted, certain of these derivative contracts have been designated for hedge accounting treatment. Certain of our derivatives that do not qualify for hedge accounting are effective as economic hedges. These derivative contracts are likewise required to be recognized each period at fair value and therefore do result in some level of volatility. The level of volatility will vary with the type and amount of derivative hedges outstanding, as well as fluctuations in the currency and interest rate markets during the period. The related cash flow impacts of all of our derivative activities are reflected as cash flows from operating activities.
By their nature, all derivative instruments involve, to varying degrees, elements of market and credit risk. The market risk associated with these instruments resulting from currency exchange and interest rate movements is expected to offset the market risk of the underlying transactions, assets and liabilities being hedged. We do not believe there is significant risk of loss in the event of non-performance by the counterparties associated with these instruments because these transactions are executed with a diversified group of major financial institutions. Further, our policy is to deal with counterparties having a minimum investment grade or better credit rating. Credit risk is managed through the continuous monitoring of exposures to such counterparties.
The current market events have not required us to materially modify or change our financial risk management strategies with respect to our exposures to interest rate and foreign currency risk. Refer to Note 12 – Financial Instruments in the Condensed Consolidated Financial Statements for further discussion and information on our financial risk management strategies.
Xerox 2021 Form 10-Q 54


Non-GAAP Financial Measures
We have reported our financial results in accordance with generally accepted accounting principles (GAAP). In addition, we have discussed our financial results using the non-GAAP measures described below. We believe these non-GAAP measures allow investors to better understand the trends in our business and to better understand and compare our results. Accordingly, we believe it is necessary to adjust several reported amounts, determined in accordance with GAAP, to exclude the effects of certain items as well as their related income tax effects.
A reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are set forth below as well as in the first quarter 2021 presentation slides available at www.xerox.com/investor.
These non-GAAP financial measures should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.
Adjusted Earnings Measures
Net Income (Loss) and EPS
Effective Tax Rate
The above measures were adjusted for the following items:
Restructuring and related costs, net: Restructuring and related costs, net include restructuring and asset impairment charges as well as costs associated with our transformation programs beyond those normally included in restructuring and asset impairment charges. Restructuring consists of costs primarily related to severance and benefits paid to employees pursuant to formal restructuring and workforce reduction plans. Asset impairment includes costs incurred for those assets sold, abandoned or made obsolete as a result of our restructuring actions, exiting from a business or other strategic business changes. Additional costs for our transformation programs are primarily related to the implementation of strategic actions and initiatives and include third-party professional service costs as well as one-time incremental costs. All of these costs can vary significantly in terms of amount and frequency based on the nature of the actions as well as the changing needs of the business. Accordingly, due to that significant variability, we will exclude these charges since we do not believe they provide meaningful insight into our current or past operating performance nor do we believe they are reflective of our expected future operating expenses as such charges are expected to yield future benefits and savings with respect to our operational performance.
Amortization of intangible assets: The amortization of intangible assets is driven by our acquisition activity which can vary in size, nature and timing as compared to other companies within our industry and from period to period. The use of intangible assets contributed to our revenues earned during the periods presented and will contribute to our future period revenues as well. Amortization of intangible assets will recur in future periods.
Transaction and related costs, net: Transaction and related costs, net are costs and expenses primarily associated with certain strategic M&A projects. These costs are primarily for third-party legal, accounting, consulting and other similar type professional services as well as potential legal settlements that may arise in connection with those M&A transactions. These costs are considered incremental to our normal operating charges and were incurred or are expected to be incurred solely as a result of the planned transactions. Accordingly, we are excluding these expenses from our Adjusted Earnings Measures in order to evaluate our performance on a comparable basis.
Non-service retirement-related costs: Our defined benefit pension and retiree health costs include several elements impacted by changes in plan assets and obligations that are primarily driven by changes in the debt and equity markets as well as those that are predominantly legacy in nature and related to employees who are no longer providing current service to the company (e.g. retirees and ex-employees). These elements include (i) interest cost, (ii) expected return on plan assets, (iii) amortization of prior plan amendments, (iv) amortized actuarial gains/losses and (v) the impacts of any plan settlements/curtailments. Accordingly, we consider these elements of our periodic retirement plan costs to be outside the operational performance of the business or legacy costs and not necessarily indicative of current or future cash flow requirements. This approach is consistent with the classification of these costs as non-operating in other expenses, net. Adjusted earnings will continue to include the service cost elements of our retirement costs, which is related to current employee service as well as the cost of our defined contribution plans.
Other discrete, unusual or infrequent items: We excluded the following item given its discrete, unusual or infrequent nature and its impact on our results for the period:
Contract termination costs - IT services
Xerox 2021 Form 10-Q 55


We believe the exclusion of these items allows investors to better understand and analyze the results for the period as compared to prior periods and expected future trends in our business.
Adjusted Operating Income and Margin
We calculate and utilize adjusted operating income and margin measures by adjusting our reported pre-tax income and margin amounts. In addition to the costs and expenses noted as adjustments for our Adjusted Earnings measures, adjusted operating income and margin also exclude the remaining amounts included in Other expenses, net, which are primarily non-financing interest expense and certain other non-operating costs and expenses. We exclude these amounts in order to evaluate our current and past operating performance and to better understand the expected future trends in our business.
Constant Currency (CC)
Refer to "Currency Impact" for a discussion of this measure and its use in our analysis of revenue growth.
Summary
Management believes that all of these non-GAAP financial measures provide an additional means of analyzing the current period’s results against the corresponding prior period’s results. However, these non-GAAP financial measures should be viewed in addition to, and not as a substitute for, the company’s reported results prepared in accordance with GAAP. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our Condensed Consolidated Financial Statements prepared in accordance with GAAP. Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. Compensation of our executives is based in part on the performance of our business based on these non-GAAP measures.
A reconciliation of these non-GAAP financial measures and the most directly comparable measures calculated and presented in accordance with GAAP are set forth on the following tables:
Net Income (Loss) and EPS reconciliation:
Three Months Ended March 31,
20212020
(in millions, except per share amounts)Net  IncomeEPSNet (Loss) IncomeEPS
Reported(1)
$39 $0.18 $(2)$(0.03)
Adjustments:
Restructuring and related costs, net17 41 
Amortization of intangible assets15 11 
Transaction and related costs, net— 17 
Non-service retirement-related costs(20)
Contract termination costs - IT services— 
Income tax on adjustments(2)
(4)(21)
Adjusted$47 $0.22 $50 $0.21 
Dividends on preferred stock used in adjusted EPS calculation(3)
$$
Weighted average shares for adjusted EPS(3)
198 216 
Fully diluted shares at March 31, 2021(4)
194
 ____________________________
(1)Net income (loss) and EPS attributable to Xerox Holdings.
(2)Refer to Effective Tax Rate reconciliation.
(3)Average shares for the calculation of adjusted diluted EPS for the three months ended March 31, 2021 and 2020 excludes 7 million shares associated with our Series A convertible preferred stock and therefore earnings include the preferred stock dividend. In addition, adjusted diluted EPS shares for 2020 include 4 million shares for potential dilutive common shares, which are not included in the GAAP EPS calculation since it was a loss.
(4)Represents common shares outstanding at March 31, 2021 plus potential dilutive common shares as used for the calculation of adjusted diluted EPS for the first quarter 2021. The amount excludes shares associated with our Series A convertible preferred stock as they were anti-dilutive for the first quarter 2021.
Xerox 2021 Form 10-Q 56


Effective Tax Rate reconciliation:
Three Months Ended March 31,
20212020
(in millions)Pre-Tax IncomeIncome Tax ExpenseEffective
Tax Rate
Pre-Tax (Loss) IncomeIncome Tax (Benefit) ExpenseEffective
Tax Rate
Reported(1)
$53 $14 26.4 %$(5)$(1)20.0 %
Non-GAAP Adjustments(2)
12 73 21 
Adjusted(3)
$65 $18 27.7 %$68 $20 29.4 %
____________________________
(1)Pre-tax income (loss) and income tax expense (benefit).
(2)Refer to Net Income (Loss) and EPS reconciliation for details.
(3)The tax impact on Adjusted Pre-Tax Income (Loss) is calculated under the same accounting principles applied to the Reported Pre-Tax Income (Loss) under ASC 740, which employs an annual effective tax rate method to the results.
Operating Income and Margin reconciliation:
Three Months Ended March 31,
20212020
(in millions)ProfitRevenueMargin(Loss) ProfitRevenueMargin
Reported(1)
$53 $1,710 3.1 %$(5)$1,860 (0.3)%
Adjustments:
Restructuring and related costs, net17 41 
Amortization of intangible assets15 11 
Transaction and related costs, net— 17 
Other expenses, net23 
Adjusted$89 $1,710 5.2 %$87 $1,860 4.7 %
____________________________
(1)Pre-Tax Income (Loss)
Xerox 2021 Form 10-Q 57


ITEM 3 — QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The information set forth under the “Financial Risk Management” section of this Quarterly Report on Form 10-Q is hereby incorporated by reference in answer to this Item.
 
ITEM 4 — CONTROLS AND PROCEDURES
(a)Evaluation of Disclosure Controls and Procedures
Xerox Holdings Corporation
The management of Xerox Holdings Corporation evaluated, with the participation of its principal executive officer and principal financial officer, or persons performing similar functions, the effectiveness of its disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this report. Based on this evaluation, the principal executive officer and principal financial officer of Xerox Holdings Corporation have concluded that, as of the end of the period covered by this report, the disclosure controls and procedures of Xerox Holdings Corporation were effective to ensure that information that is required to be disclosed in the reports that is filed or submitted under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms relating to Xerox Holdings Corporation, including its consolidated subsidiaries, and was accumulated and communicated to the management of Xerox Holdings Corporation, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. 
Xerox Corporation
The management of Xerox Corporation evaluated, with the participation of its principal executive officer and principal financial officer, or persons performing similar functions, the effectiveness of its disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this report. Based on this evaluation, the principal executive officer and principal financial officer of Xerox Corporation have concluded that, as of the end of the period covered by this report, the disclosure controls and procedures of Xerox Corporation were effective to ensure that information that is required to be disclosed in the reports that is filed or submitted under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms relating to Xerox Corporation, including its consolidated subsidiaries, and was accumulated and communicated to the management of Xerox Corporation, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. 
(b)Changes in Internal Controls
Xerox Holdings Corporation
As required by paragraph (d) of Rule 13a-15 under the Exchange Act, we evaluated changes in our internal control over financial reporting during the last fiscal quarter. There were no changes identified in our internal control over financial reporting that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Xerox Corporation
As required by paragraph (d) of Rule 13a-15 under the Exchange Act, we evaluated changes in our internal control over financial reporting during the last fiscal quarter. There were no changes identified in our internal control over financial reporting that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Xerox 2021 Form 10-Q 58


PART II — OTHER INFORMATION

ITEM 1 — LEGAL PROCEEDINGS
The information set forth under Note 19 – Contingencies and Litigation in the Condensed Consolidated Financial Statements of this Quarterly Report on Form 10-Q is incorporated by reference in answer to this item.
 
ITEM 1A — RISK FACTORS
Reference is made to the Risk Factors set forth in Part I, Item 1A of the combined Xerox Holdings Corporation and Xerox Corporation Annual Report on Form 10-K for the year ended December 31, 2020.
ITEM 2 — UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
(a)Sales of Unregistered Securities during the Quarter ended March 31, 2021
During the quarter ended March 31, 2021, Xerox Holdings Corporation issued the following securities in transactions that were not registered under the Securities Act of 1933, as amended (the Act).
Dividend Equivalent:
(a)Securities issued on January 29, 2021: Xerox Holdings Corporation issued 1,947 DSUs, representing the right to receive shares of Common Stock, par value $1 per share, at a future date.
(b)No underwriters participated. The shares were issued to each of the non-employee Directors of Xerox Holdings Corporation: Jonathan Christodoro, Keith Cozza, Joseph J. Echevarria, Nicholas Graziano, Cheryl Gordon Krongard and Scott Letier.
(c)The DSUs were issued at a deemed purchase price of $22.995 per DSU (aggregate price $44,771), based upon the market value on the date of record, in payment of the dividend equivalents due to DSU holders pursuant to Xerox Holdings Corporation's 2004 Equity Compensation Plan for Non-Employee Directors (as amended and restated in 2019 (the 2019 Restatement)).
(d)Exemption from registration under the Act was claimed based upon Section 4(2) as a sale by an issuer not involving a public offering.
(b) Issuer Purchases of Equity Securities during the Quarter ended March 31, 2021
In January 2021, the Xerox Holdings Corporation's Board of Directors authorized an additional $100 million of share repurchase authority, bringing the total authorization of the already existing share repurchase program to $1.1 billion (excluding fees and expenses).
Repurchases of Xerox Holdings Corporation's Common Stock, par value $1 per share, include the following:
Board Authorized Share Repurchase Program:
Total Number of Shares Purchased
Average Price Paid per Share(1)
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)
Maximum Approximate Dollar Value of Shares That May Yet Be  Purchased Under the  Plans or Programs(2)
January 1 through 31— $— — $500,450,199
February 1 through 283,698,545 23.67 3,698,545 412,918,420
March 1 through 313,005,520 24.86 3,005,520 338,195,131
Total6,704,065 6,704,065 
 ____________________________
(1)Exclusive of fees and expenses.
(2)Of the $1.1 billion of share repurchase authority previously granted by Xerox Holdings Corporation's Board of Directors, exclusive of fees and expenses, approximately $762 million has been used through March 31, 2021. Repurchases may be made on the open market, or through derivative or negotiated contracts. Open-market repurchases will be made in compliance with the Securities and Exchange Commission's Rule 10b-18, and are subject to market conditions, as well as applicable legal and other considerations.
Xerox 2021 Form 10-Q 59


Repurchases Related to Stock Compensation Programs(1):
Total Number of Shares Purchased
 Average Price Paid per Share(2)
Total Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsMaximum Approximate Dollar Value of Shares That May Yet Be  Purchased Under the  Plans or Programs
January 1 through 31168,032 $23.00 n/an/a
February 1 through 28498 23.35 n/an/a
March 1 through 31646 24.97 n/an/a
Total169,176 
 ____________________________
(1)These repurchases are made under a provision in our restricted stock compensation programs for the indirect repurchase of shares through a net-settlement feature upon the vesting of shares in order to satisfy minimum statutory tax-withholding requirements.
(2)Exclusive of fees and expenses.
ITEM 3 — DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4 — MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5 — OTHER INFORMATION
None.
ITEM 6 — EXHIBITS
Xerox 2021 Form 10-Q 60


101
The following financial information from Xerox Holdings Corporation and Xerox Corporation's combined Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 was formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Xerox Holdings Corporation Condensed Consolidated Statements of Income (Loss), (ii) Xerox Holdings Corporation Condensed Consolidated Statements of Comprehensive Income (Loss), (iii) Xerox Holdings Corporation Condensed Consolidated Balance Sheets, (iv) Xerox Holdings Corporation Condensed Consolidated Statements of Cash Flows, (v) Xerox Corporation Condensed Consolidated Statements of Income (Loss), (vi) Xerox Corporation Condensed Consolidated Statements of Comprehensive Income (Loss), (vii) Xerox Corporation Condensed Consolidated Balance Sheets, (viii) Xerox Corporation Condensed Consolidated Statements of Cash Flows, and (ix) Notes to the Condensed Consolidated Financial Statements.
104The cover page from this Quarterly Report on Form 10-Q, (formatted as Inline XBRL and contained in Exhibit 101).

Xerox 2021 Form 10-Q 61


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, each registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. The signatures for each undersigned shall be deemed to relate only to matters having reference to such company and its subsidiaries.
XEROX HOLDINGS CORPORATION
(Registrant)
By:
/S/ JOSEPH H. MANCINI, JR.
 
Joseph H. Mancini, Jr.
Vice President and
Chief Accounting Officer
(Principal Accounting Officer)
Date: April 30, 2021

 
XEROX CORPORATION
(Registrant)
By:
/S/ JOSEPH H. MANCINI, JR.
 
Joseph H. Mancini, Jr.
Vice President and
Chief Accounting Officer
(Principal Accounting Officer)
Date: April 30, 2021
 
Xerox 2021 Form 10-Q 62


EXHIBIT INDEX

Xerox 2021 Form 10-Q 63


101The following financial information from Xerox Holdings Corporation and Xerox Corporation's combined Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 was formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Xerox Holdings Corporation Condensed Consolidated Statements of Income (Loss), (ii) Xerox Holdings Corporation Condensed Consolidated Statements of Comprehensive Income (Loss), (iii) Xerox Holdings Corporation Condensed Consolidated Balance Sheets, (iv) Xerox Holdings Corporation Condensed Consolidated Statements of Cash Flows, (v) Xerox Corporation Condensed Consolidated Statements of Income (Loss), (vi) Xerox Corporation Condensed Consolidated Statements of Comprehensive Income (Loss), (vii) Xerox Corporation Condensed Consolidated Balance Sheets, (viii) Xerox Corporation Condensed Consolidated Statements of Cash Flows, and (ix) Notes to the Condensed Consolidated Financial Statements.
104The cover page from this Quarterly Report on Form 10-Q, (formatted as Inline XBRL and contained in Exhibit 101).

Xerox 2021 Form 10-Q 64

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
4/1/23
12/31/22
1/1/22
12/31/2110-K,  SD
9/10/21
5/6/21
Filed on:4/30/214,  SC 13D/A
4/12/21
4/9/21
4/8/214
4/7/21DEF 14A
For Period end:3/31/21
3/10/21
1/29/21
1/20/21
1/15/214
1/13/214
1/7/214/A
1/1/21
12/31/2010-K,  SD
12/23/20
12/16/20
12/14/20
10/21/20
10/16/20
10/1/204
8/24/208-K
8/10/20
8/7/204,  SC 13D/A
7/23/20
3/31/2010-Q,  425,  8-K,  RW,  SC TO-T/A
3/6/208-K,  S-4/A,  SEC LETTER
2/25/20
1/21/20
1/15/204
1/6/20425,  8-K
12/31/1910-K,  SD
12/26/19
12/13/19
7/18/19
7/12/19
6/4/19
5/16/194,  425,  DEFA14A
4/11/19
1/14/194,  4/A
12/6/18
5/24/18
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/23/24  Xerox Holdings Corp.              10-K       12/31/23  195:41M
 2/23/23  Xerox Holdings Corp.              10-K       12/31/22  191:38M
 2/23/22  Xerox Holdings Corp.              10-K       12/31/21  190:35M
 8/04/21  Xerox Holdings Corp.              10-Q        6/30/21  109:18M
 6/29/21  Xerox Holdings Corp.              S-8         6/29/21    3:73K                                    Donnelley … Solutions/FA
 6/29/21  Xerox Holdings Corp.              S-8         6/29/21    3:76K                                    Donnelley … Solutions/FA


2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/25/21  Xerox Holdings Corp.              10-K       12/31/20  164:33M
 1/26/21  Xerox Holdings Corp.              8-K:1,9     1/26/21   14:613K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001770450-21-000025   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., Apr. 24, 9:38:12.2am ET